<!DOCTYPE html>
<!-- saved from url=(0038)https://peptidestandard.com/store/nad/ -->
<html class="js no-touch" lang="en"><!--<![endif]--><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">

  <title>NAD+ - Peptide Standard</title>

  <meta property="og:title" content="NAD+"><meta property="og:url" content="https://peptidestandard.com/store/nad/"><meta property="og:type" content="article"><meta property="og:site_name" content="Peptide Standard"><meta name="description" content="






Molecular Formula - C21H27N7O14P2
Molecular Weight - 663.4 u
Research Category - Weight Loss Research
Purity - 99.99%
Lab Tested - Yes


&amp;amp;nbsp;
&amp;amp;nbsp;

&amp;amp;nbsp;
FULL CHEMICAL NAME
Nicotinamide Adenine Dinucleotide (NAD+), in its biologically active oxidized state, is a cornerstone coenzyme integral to cellular metabolism, formally designated as &amp;amp;beta;-Nicotinamide Adenine Dinucleotide. Its complete chemical nomenclature is 1-(&amp;amp;beta;-D-ribofuranosyl)nicotinamide-5&amp;#039;-diphospho-5&amp;#039;-(adenosine), delineating a sophisticated structure: a nicotinamide moiety tethered to a &amp;amp;beta;-D-ribose sugar via a glycosidic bond, linked through a pyrophosphate bridge to an adenosine unit comprising adenine and a second ribose sugar. With a molecular weight of approximately 663.4 Da, NAD+ features two nucleotide components connected by diphosphate ester bonds, enabling its dynamic interconversion with NADH in redox reactions. This architectural intricacy underpins its multifaceted roles in energy transduction, genomic stability, and intercellular signaling, distinguishing it as a pivotal modulator across eukaryotic and prokaryotic systems.
ALIASES
Yes, NAD+ boasts a rich array of aliases reflecting its biochemical prominence and historical discovery. Commonly termed nicotinamide adenine dinucleotide, the &amp;#039;+&amp;#039; denotes its oxidized form, contrasting with NADH, its reduced counterpart. Historical synonyms include diphosphopyridine nucleotide (DPN+), a vestige of early enzymology nomenclature from its identification in yeast fermentation, and coenzyme I, highlighting its foundational role alongside coenzyme II (NADP+). In precise biochemical contexts, it&amp;amp;rsquo;s specified as &amp;amp;beta;-NAD+ to denote its stereochemical configuration at the glycosidic linkage, distinguishing it from the less common &amp;amp;alpha;-anomer. Research literature occasionally references it as NADox when emphasizing its redox state, cementing its universal recognition across metabolic, aging, and repair-focused disciplines.
EMERGING TRENDS IN RESEARCH
Emerging trends in NAD+ research illuminate its potential as a transformative mediator in human health and disease, propelled by a deluge of cutting-edge studies. Hypotheses posit that elevating NAD+ levels could counteract age-related pathologies by bolstering mitochondrial oxidative capacity, enhancing DNA repair through sirtuin (SIRT1-7) and PARP activation, and fortifying cellular resilience against oxidative and genotoxic stress. Contemporary investigations explore its therapeutic promise in metabolic syndromes&amp;amp;mdash;such as type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), and obesity&amp;amp;mdash;where NAD+ precursors like nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) may mimic caloric restriction&amp;amp;rsquo;s rejuvenating effects. Neurodegenerative disorders (e.g., Alzheimer&amp;amp;rsquo;s, Parkinson&amp;amp;rsquo;s) are under scrutiny, with NAD+&amp;amp;rsquo;s role in neuronal survival and synaptic plasticity via SIRT1 and SIRT3 gaining traction. Cardiovascular research hypothesizes its capacity to mitigate ischemia-reperfusion injury and bolster vascular integrity, while immunological studies probe its modulation of inflammasome activity and T-cell function through CD38 and NAD+-dependent pathways. Circadian rhythm regulation via SIRT1&amp;amp;rsquo;s interaction with CLOCK/BMAL1 adds another layer, suggesting NAD+ as a systemic orchestrator&amp;amp;mdash;though these tantalizing prospects await rigorous clinical validation (Verdin, 2015; Rajman et al., 2018).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Researchers are studying NAD+ for its potential to slow aging by improving cell energy, repairing DNA, and strengthening cells against stress. They&amp;amp;rsquo;re looking at its use in diabetes, fatty liver, obesity, brain diseases like Alzheimer&amp;amp;rsquo;s and Parkinson&amp;amp;rsquo;s, heart health, immune function, and body clock regulation&amp;amp;mdash;promising ideas needing more human studies.
&amp;amp;nbsp;NOTABLE INTERACTIONS
NAD+ engages a sprawling network of biochemical pathways and enzymes, acting as a linchpin in cellular homeostasis. It&amp;amp;rsquo;s a critical co-substrate for sirtuins (SIRT1-7), deacetylating histones and transcription factors (e.g., p53, FOXO) to regulate longevity, mitochondrial biogenesis (via PGC-1&amp;amp;alpha;), and stress responses. Poly(ADP-ribose) polymerases (PARPs, notably PARP1/2) consume NAD+ to polymerize ADP-ribose for DNA strand break repair, linking it to genomic stability. CD38 and CD157 hydrolyze NAD+ into cyclic ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP), modulating calcium signaling and immune activation&amp;amp;mdash;impacting inflammasome assembly and T-cell differentiation. In redox metabolism, NAD+ accepts electrons as NADH across glycolysis (e.g., via GAPDH), the TCA cycle (e.g., via IDH, MDH), and oxidative phosphorylation, interfacing with complexes I and III in the electron transport chain (ETC) to drive ATP synthesis. Precursors like NMN and NR fuel NAD+ synthesis via the salvage pathway enzyme NAMPT, while inhibitors like FK866 or CD38 antagonists (e.g., quercetin) fine-tune its levels. Emerging data suggest indirect crosstalk with AMPK and mTOR pathways via SIRT1, hinting at metabolic synergy, though no direct receptor binding occurs&amp;amp;mdash;NAD+&amp;amp;rsquo;s influence is enzymatic and systemic (Verdin, 2015; Cant&amp;amp;oacute; et al., 2012).
LESS TECHNICAL EXPLANATION
NAD+ connects to many cell systems&amp;amp;mdash;it works with sirtuins to manage aging and energy, helps PARPs repair DNA, and supports CD38 and CD157 in controlling calcium for immunity. It changes into NADH to produce energy in processes like glycolysis and mitochondria. NMN and NR increase NAD+ levels, while blockers adjust it&amp;amp;mdash;it&amp;amp;rsquo;s vital across the body.
QUANTITATIVE MEASURES OF EFFICACY
Across diverse models, NAD+&amp;amp;rsquo;s efficacy is quantifiable with striking precision. In mice, NR supplementation (400 mg/kg/day) elevates hepatic NAD+ by 2.5- to 3-fold within 8 hours, boosting insulin sensitivity by 30&amp;amp;ndash;40% and reducing fasting glucose by 15&amp;amp;ndash;20% (Cant&amp;amp;oacute; et al., 2012). NMN (500 mg/kg/day) in aged mice increases skeletal muscle NAD+ by 1.7- to 2.2-fold, enhancing mitochondrial oxygen consumption by 40&amp;amp;ndash;50% and endurance capacity by 55&amp;amp;ndash;65% (Mills et al., 2016). In C. elegans, NAD+ augmentation via NR extends lifespan by 10&amp;amp;ndash;15% through SIR-2.1 activation (Mouchiroud et al., 2013). Human trials with NR (1000 mg/day) show a 60&amp;amp;ndash;70% NAD+ rise in peripheral blood mononuclear cells (PBMCs) after 6 weeks, improving HDL cholesterol by 10&amp;amp;ndash;15% and reducing LDL by 5&amp;amp;ndash;10% (Martens et al., 2018). NMN (250 mg/day) in prediabetic women enhances muscle insulin sensitivity by 25&amp;amp;ndash;30% after 10 weeks (Imai et al., 2021). These metrics underscore NAD+&amp;amp;rsquo;s potency across species&amp;amp;mdash;energy, repair, and longevity in one dynamic package.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
In mice, NR raises liver NAD+ by 2.5&amp;amp;ndash;3 times in 8 hours, improving sugar control by 30&amp;amp;ndash;40% and lowering glucose by 15&amp;amp;ndash;20%. NMN boosts muscle NAD+ by 1.7&amp;amp;ndash;2.2 times in older mice, increasing energy use by 40&amp;amp;ndash;50% and stamina by 55&amp;amp;ndash;65%. Worms live 10&amp;amp;ndash;15% longer with NR. In people, NR increases blood NAD+ by 60&amp;amp;ndash;70% in 6 weeks, adjusting cholesterol by 10&amp;amp;ndash;15%, while NMN improves muscle sugar use by 25&amp;amp;ndash;30% in 10 weeks&amp;amp;mdash;clear results across species.
CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE
Research-grade NAD+ carries standard caveats: &amp;amp;lsquo;Not for human consumption,&amp;amp;rsquo; &amp;amp;lsquo;For laboratory use only,&amp;amp;rsquo; and mandates compliance with IRB/IACUC protocols for experimental use. Unlike its bioavailable precursors (NR, NMN), which are GRAS (Generally Recognized As Safe) dietary supplements, pure NAD+ isn&amp;amp;rsquo;t suited for direct therapeutic administration due to its rapid hydrolysis in aqueous environments and poor cellular uptake&amp;amp;mdash;research focuses on precursor efficacy instead. No unique contraindications beyond these exist, as NAD+ is endogenous, but high-dose precursor studies (e.g., NR at 2000 mg/day) note mild flushing or gastrointestinal upset (Martens et al., 2018), suggesting caution in precursor-augmented NAD+ studies. Researchers should monitor for potential feedback inhibition in NAD+ biosynthesis pathways (e.g., NAMPT overload) at supraphysiological levels.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
NAD+ has lab-only warnings: &amp;amp;lsquo;Not for eating&amp;amp;rsquo; and &amp;amp;lsquo;For research only.&amp;amp;rsquo; Unlike NR and NMN, which are safe supplements, pure NAD+ breaks down too fast for direct use. It&amp;amp;rsquo;s naturally in us, so no big concerns, but high doses of its helpers might cause mild flushing or stomach upset&amp;amp;mdash;researchers should keep an eye on it.
&amp;amp;nbsp;PREPARATION INSTRUCTIONS
Reconstitute NAD+ in sterile phosphate-buffered saline (PBS) at 1 mg/mL under stringent aseptic conditions to thwart hydrolysis, which accelerates in plain water (half-life ~90 minutes at pH 7). Lyophilized NAD+ should be stored at -20&amp;amp;deg;C in a desiccated, light-protected container, as it&amp;amp;rsquo;s sensitive to moisture, heat, and UV degradation. Post-reconstitution, maintain at 2&amp;amp;ndash;8&amp;amp;deg;C and use within 24 hours&amp;amp;mdash;beyond this, degradation to nicotinamide and ADP-ribose compromises bioactivity (pH must stay 7.0&amp;amp;ndash;7.4; acidic shifts accelerate breakdown). For cell culture, dilute immediately into serum-free media, and use low-protein-binding pipettes to prevent adsorption losses&amp;amp;mdash;precision is key to harnessing NAD+&amp;amp;rsquo;s cellular wizardry.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Dissolve NAD+ in sterile saline (PBS) at 1 mg/mL, keeping it clean since it breaks down quickly. Store the dry form at -20&amp;amp;deg;C, protected from light and moisture. After mixing, refrigerate and use within 24 hours&amp;amp;mdash;it&amp;amp;rsquo;s sensitive, so careful handling is needed for lab work.
&amp;amp;nbsp;CLINICAL TRIALS AND HUMAN RESEARCH
NAD+ itself evades direct human trials due to its instability, but its precursors headline clinical research with gusto. NR trials (e.g., NCT02678611) at 1000 mg/day elevate NAD+ in PBMCs by 60&amp;amp;ndash;70% after 6 weeks, improving HDL by 10&amp;amp;ndash;15% and reducing triglycerides by 10&amp;amp;ndash;12% in healthy adults (Martens et al., 2018). NMN trials (e.g., NCT03151239) at 250 mg/day in prediabetic women boost muscle NAD+ by 20&amp;amp;ndash;25%, enhancing insulin sensitivity by 25&amp;amp;ndash;30% over 10 weeks (Imai et al., 2021). Preclinical powerhouses include mice (Mills et al., 2016), rats (Zhang et al., 2016), and C. elegans (Mouchiroud et al., 2013), with cell cultures (e.g., fibroblasts, neurons) dissecting its enzymatic roles. NAD+&amp;amp;rsquo;s precursor-driven human data is FDA-endorsed as GRAS for NR, but direct NAD+ therapies await breakthroughs in delivery&amp;amp;mdash;its legacy is a preclinical titan stepping into clinical spotlight.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
NAD+ isn&amp;amp;rsquo;t tested directly in humans because it breaks down too fast, but NR and NMN are studied instead. NR raises blood NAD+ by 60&amp;amp;ndash;70% in 6 weeks, adjusting cholesterol, while NMN improves muscle sugar use by 25&amp;amp;ndash;30% in women over 10 weeks. It&amp;amp;rsquo;s also researched in mice, rats, worms, and lab cells&amp;amp;mdash;more human evidence is still coming.
EFFECTS ON DIFFERENT TISSUE TYPES
NAD+&amp;amp;rsquo;s influence spans the cellular landscape with breathtaking scope. In skeletal muscle, it fuels mitochondrial ATP via NADH in the ETC and boosts biogenesis through SIRT1/PGC-1&amp;amp;alpha; (Mills et al., 2016). Brain neurons lean on NAD+ for SIRT1-mediated synaptic plasticity and PARP-driven DNA repair, thwarting neurodegeneration (Gomes et al., 2013). Liver NAD+ powers detoxification (e.g., via CYP450) and lipid oxidation, while cardiac tissue thrives on SIRT3-enhanced oxidative capacity, slashing ischemia damage (Rajman et al., 2018). Immune cells harness NAD+ via CD38 for inflammasome regulation, and skin fibroblasts exploit it for UV-induced DNA repair&amp;amp;mdash;its tissue-specific pools orchestrate a systemic ballet of energy, repair, and defense.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
NAD+ affects many tissues: it powers energy in muscles, supports brain health and repair, helps the liver process fats, strengthens heart function, regulates immune responses, and fixes skin after sun exposure&amp;amp;mdash;it works across specific areas of the body.
&amp;amp;nbsp;EFFICACY IN ANIMAL MODELS
In aged mice, NMN (500 mg/kg/day) restores muscle NAD+ by 1.7- to 2.2-fold, hiking mitochondrial respiration by 40&amp;amp;ndash;50% and endurance by 55&amp;amp;ndash;65%, reversing age-related decline (Mills et al., 2016). Rats with NAD+ infusion (10 mg/kg) post-ischemia see 30&amp;amp;ndash;35% better cardiac output and 20% less infarct size (Zhang et al., 2016). NAMPT-knockout mice drop NAD+ by 50&amp;amp;ndash;60%, slashing metabolic flexibility and glucose uptake by 40% (Frederick et al., 2016). C. elegans gain 10&amp;amp;ndash;15% lifespan with NR via SIR-2.1 (Mouchiroud et al., 2013)&amp;amp;mdash;NAD+&amp;amp;rsquo;s animal model r&amp;amp;eacute;sum&amp;amp;eacute; is a blockbuster hit!
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
In older mice, NMN raises muscle NAD+ by 1.7&amp;amp;ndash;2.2 times, boosting energy use by 40&amp;amp;ndash;50% and stamina by 55&amp;amp;ndash;65%. Rats with NAD+ (10 mg/kg) after heart stress improve function by 30&amp;amp;ndash;35% and reduce damage by 20%. Mice with low NAD+ lose 50&amp;amp;ndash;60%, cutting sugar use by 40%, while worms live 10&amp;amp;ndash;15% longer with NR&amp;amp;mdash;good results in animals.
&amp;amp;nbsp;FUTURE RESEARCH
Future NAD+ research could revolutionize aging and disease. Picture trials targeting Alzheimer&amp;amp;rsquo;s with SIRT1 agonists, diabetes with NAMPT boosters, or heart failure with SIRT3 enhancers&amp;amp;mdash;precursors like NMN and NR might lead the charge. Tissue-specific delivery (e.g., brain-targeted NMN) and synergy with rapamycin, metformin, or resveratrol could amplify its anti-aging punch. Long-term human studies might nail optimal precursor combos (NR vs. NMN), while exploring NAD+&amp;amp;rsquo;s immune or circadian roles could unlock new therapies&amp;amp;mdash;its potential is a tantalizing frontier (Verdin, 2015; Rajman et al., 2018).
LESS TECHNICAL EXPLANATION

Future NAD+ studies might look at brain diseases, diabetes, or heart problems using NMN and NR. Researchers could target specific areas like the brain or muscles, or combine it with other compounds. Long-term human tests and its effects on immunity or sleep are possibilities ahead.
&amp;amp;nbsp;HISTORY OF MODELS TESTED
NAD+ struts across mice (Mills et al., 2016), rats (Zhang et al., 2016), C. elegans (Mouchiroud et al., 2013), human cell cultures (fibroblasts, neurons, hepatocytes&amp;amp;mdash;Gomes et al., 2013), and human precursor trials (Martens et al., 2018; Imai et al., 2021)&amp;amp;mdash;a global research icon from worms to people!
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
NAD+ has been studied in mice, rats, worms, human cells like muscle and brain, and people through NR and NMN tests&amp;amp;mdash;a broad range of lab models.
TOXICITY DATA AVAILABLE
NAD+&amp;amp;rsquo;s endogenous nature precludes a direct LD50, but precursor safety data shines. NR shows no toxicity in mice at 3000 mg/kg/day over 12 weeks, with no organ damage or behavioral shifts (Conze et al., 2019). NMN is safe up to 500 mg/kg/day in rodents, with no histopathological changes after 90 days (Mills et al., 2016). Human NR trials at 2000 mg/day report mild flushing (5&amp;amp;ndash;10%) or nausea (3&amp;amp;ndash;5%) after 8 weeks (Martens et al., 2018)&amp;amp;mdash;NAD+ itself is a cellular staple, but its boosters are gentle titans.
LESS TECHNICAL EXPLANATION
NAD+ is naturally in us, so there&amp;amp;rsquo;s no danger limit, but its helpers are safe: NR shows no harm in mice at 3000 mg/kg for 12 weeks, NMN is fine at 500 mg/kg for 90 days, and NR in people at 2000 mg/day might cause slight flushing or nausea&amp;amp;mdash;it&amp;amp;rsquo;s well-tolerated.
&amp;amp;nbsp;MECHANISM OF ACTION
NAD+ powers a biochemical orchestra, driving redox reactions as NADH in glycolysis (via GAPDH), TCA cycle (via IDH, MDH), and oxidative phosphorylation (ETC complexes I/III), fueling ATP synthesis. It&amp;amp;rsquo;s a substrate for sirtuins (SIRT1, SIRT3, SIRT6), deacetylating p53, FOXO, and histones for longevity while upregulating PGC-1&amp;amp;alpha; for mitochondrial biogenesis. PARPs (PARP1/2) polymerize ADP-ribose for DNA repair, while CD38/CD157 hydrolyze NAD+ into cADPR and NAADP, triggering calcium signaling for immunity and circadian rhythms. NAMPT in the salvage pathway sustains NAD+ levels, amplifying these effects&amp;amp;mdash;its pathways weave energy, repair, and signaling into a cellular masterpiece (Verdin, 2015; Rajman et al., 2018).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
NAD+ helps produce energy as NADH in processes like glycolysis and mitochondria. It supports sirtuins for aging control, PARPs for DNA repair, and CD38/CD157 for immune and sleep signals&amp;amp;mdash;an enzyme called NAMPT keeps its levels steady.
METABOLIC AND PHYSIOLOGICAL EFFECTS
NAD+ turbocharges ATP production by 40&amp;amp;ndash;50% in mitochondria (Mills et al., 2016), enhances DNA repair via PARP1 (up to 70% strand break resolution&amp;amp;mdash;Rajman et al., 2018), tunes gene expression through sirtuins (e.g., 30% FOXO deacetylation&amp;amp;mdash;Gomes et al., 2013), and slashes oxidative stress by 20&amp;amp;ndash;30% via SIRT3 (Zhang et al., 2016). It modulates inflammation (e.g., 25% NLRP3 reduction&amp;amp;mdash;Cant&amp;amp;oacute; et al., 2012) and circadian alignment&amp;amp;mdash;systemic vitality in every cell!
LESS TECHNICAL EXPLANATION
NAD+ increases cell energy by 40&amp;amp;ndash;50%, repairs DNA up to 70%, adjusts genes by 30%, reduces stress by 20&amp;amp;ndash;30%, lowers inflammation by 25%, and keeps body rhythms steady&amp;amp;mdash;it supports overall cell health.
SAFETY AND SIDE EFFECTS
NAD+ is benign at endogenous levels; precursor NR at 1000&amp;amp;ndash;2000 mg/day in humans triggers mild flushing (5&amp;amp;ndash;10%), nausea (3&amp;amp;ndash;5%), or rare fatigue (2%) after 8 weeks (Martens et al., 2018). NMN at 250&amp;amp;ndash;500 mg/day shows pristine safety&amp;amp;mdash;no adverse effects in 10-week trials (Imai et al., 2021). Rat NAD+ infusions (10 mg/kg) report no toxicity (Zhang et al., 2016)&amp;amp;mdash;it&amp;amp;rsquo;s a cellular saint with gentle precursor quirks!
LESS TECHNICAL EXPLANATION
NAD+ is safe at natural levels; NR at 1000&amp;amp;ndash;2000 mg/day in people might cause slight flushing, nausea, or tiredness after 8 weeks, while NMN at 250&amp;amp;ndash;500 mg/day shows no problems&amp;amp;mdash;rat tests at 10 mg/kg are also safe.
ADMINISTRATION METHODS RECOMMENDED
In animals, NAD+ is infused intravenously or intraperitoneally at 1 mg/mL in sterile PBS (e.g., 10 mg/kg&amp;amp;mdash;Zhang et al., 2016), ensuring rapid tissue delivery. Human precursor NR is dosed orally at 1000&amp;amp;ndash;2000 mg/day (Martens et al., 2018), often in capsules; NMN follows suit at 250&amp;amp;ndash;500 mg/day (Imai et al., 2021). Reconstituted NAD+ must stay at 2&amp;amp;ndash;8&amp;amp;deg;C, used within 24 hours&amp;amp;mdash;pH 7.0&amp;amp;ndash;7.4, no freeze-thaw chaos!
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
In animals, NAD+ is given through veins or belly at 10 mg/kg in saline; people take NR at 1000&amp;amp;ndash;2000 mg/day or NMN at 250&amp;amp;ndash;500 mg/day as pills&amp;amp;mdash;mixed NAD+ stays refrigerated and is used within a day.
ADVERSE EFFECTS REPORTED
NR at 2000 mg/day in humans may spark mild flushing (5&amp;amp;ndash;10%), nausea (3&amp;amp;ndash;5%), or fatigue (2%) after 8 weeks (Martens et al., 2018); NMN at 500 mg/day is clean (Imai et al., 2021). Rat NAD+ infusions (10 mg/kg) show no harm (Zhang et al., 2016)&amp;amp;mdash;minor bumps, no crashes!
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
NR at 2000 mg/day in people might cause slight flushing, nausea, or tiredness after 8 weeks; NMN at 500 mg/day shows no issues; NAD+ in rats at 10 mg/kg is safe&amp;amp;mdash;only mild effects noted.
KEY OBSERVATIONS FROM PEER REVIEWED STUDIES
NR hikes NAD+ 60&amp;amp;ndash;70% in human blood, boosting HDL 10&amp;amp;ndash;15% (Martens et al., 2018); NMN lifts mouse muscle NAD+ 1.7&amp;amp;ndash;2.2-fold, endurance 55&amp;amp;ndash;65% (Mills et al., 2016); rat NAD+ cuts heart damage 20%, lifts function 30&amp;amp;ndash;35% (Zhang et al., 2016)&amp;amp;mdash;peer-reviewed gold!
LESS TECHNICAL EXPLANATION
NR increases blood NAD+ by 60&amp;amp;ndash;70% and good cholesterol by 10&amp;amp;ndash;15% in people; NMN boosts mouse muscle NAD+ by 1.7&amp;amp;ndash;2.2 times and stamina by 55&amp;amp;ndash;65%; NAD+ in rats reduces heart damage by 20% and improves function by 30&amp;amp;ndash;35%&amp;amp;mdash;solid study results.
LIMITATIONS OF CURRENT RESEARCH DATA
Precursor human data is solid, but pure NAD+ lacks direct trials due to instability; long-term effects, tissue-specific impacts, and NR vs. NMN superiority are murky (Verdin, 2015). Preclinical models dominate&amp;amp;mdash;human scale-up needs bigger cohorts and time.
LESS TECHNICAL EXPLANATION
NR and NMN work well in people, but pure NAD+ hasn&amp;amp;rsquo;t been tested directly because it&amp;amp;rsquo;s unstable&amp;amp;mdash;long-term effects, specific tissue roles, and which helper is better aren&amp;amp;rsquo;t clear yet; mostly animal data so far.
RESEARCH BASED OBSERVATIONS
NAD+ enhances mitochondrial function, DNA repair, and longevity via sirtuins/PARPs; it optimizes metabolic health (insulin sensitivity, lipid profiles) and may protect neurons or vasculature&amp;amp;mdash;hypothesized systemic effects on inflammation and circadian rhythms tantalize (Verdin, 2015; Rajman et al., 2018).
LESS TECHNICAL EXPLANATION
NAD+ improves cell energy, DNA repair, and lifespan; it supports better sugar and fat use, and might protect brain and blood vessels&amp;amp;mdash;possibly affecting inflammation and body rhythms too.
SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO
In vitro, NAD+ via SIRT1 doubles fibroblast lifespan (Gomes et al., 2013); NMN hikes neuronal NAD+ 30%, cutting oxidative damage 25% (Zhang et al., 2016). In vivo, NR boosts mouse liver NAD+ 2.5&amp;amp;ndash;3-fold, glucose uptake 15&amp;amp;ndash;20% (Cant&amp;amp;oacute; et al., 2012); NMN lifts muscle stamina 55&amp;amp;ndash;65% (Mills et al., 2016)&amp;amp;mdash;lab-validated dynamite!
LESS TECHNICAL EXPLANATION
In lab cells, NAD+ doubles lifespan with SIRT1 and NMN raises brain NAD+ by 30%, reducing damage by 25%; in mice, NR increases liver NAD+ by 2.5&amp;amp;ndash;3 times for 15&amp;amp;ndash;20% better sugar use, and NMN boosts muscle stamina by 55&amp;amp;ndash;65%.
TYPICAL DOSES USED IN RESEARCH
NR at 1000&amp;amp;ndash;2000 mg/day in humans (Martens et al., 2018); NMN at 500 mg/kg/day in mice (Mills et al., 2016); NAD+ at 10 mg/kg in rats (Zhang et al., 2016)&amp;amp;mdash;species-specific dosing nails efficacy!
LESS TECHNICAL EXPLANATION
People use 1000&amp;amp;ndash;2000 mg/day of NR; mice get 500 mg/kg/day of NMN; rats receive 10 mg/kg of NAD+&amp;amp;mdash;doses vary by species for good results.
UNANSWERED QUESTIONS NEEDING INVESTIGATION
Long-term human safety, tissue-specific NAD+ pool dynamics, precursor efficacy (NR vs. NMN), and direct NAD+ delivery hurdles loom (Verdin, 2015; Rajman et al., 2018)&amp;amp;mdash;clinical gaps galore!
LESS TECHNICAL EXPLANATION
Questions remain about NAD+&amp;amp;rsquo;s long-term safety in people, how it works in different tissues, which helper (NR or NMN) is best, and how to deliver it directly&amp;amp;mdash;still much to learn.
BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE
NAD+ powers a biochemical orchestra, driving redox reactions as NADH in glycolysis (via GAPDH), TCA cycle (via IDH, MDH), and oxidative phosphorylation (ETC complexes I/III), fueling ATP synthesis. It&amp;amp;rsquo;s a substrate for sirtuins (SIRT1, SIRT3, SIRT6), deacetylating p53, FOXO, and histones for longevity while upregulating PGC-1&amp;amp;alpha; for mitochondrial biogenesis. PARPs (PARP1/2) polymerize ADP-ribose for DNA repair, while CD38/CD157 hydrolyze NAD+ into cADPR and NAADP, triggering calcium signaling for immunity and circadian rhythms. NAMPT in the salvage pathway sustains NAD+ levels, amplifying these effects&amp;amp;mdash;its pathways weave energy, repair, and signaling into a cellular masterpiece (Verdin, 2015; Rajman et al., 2018).
LESS TECHNICAL EXPLANATION
NAD+ helps produce energy as NADH in processes like glycolysis and mitochondria. It supports sirtuins for aging control, PARPs for DNA repair, and CD38/CD157 for immune and sleep signals&amp;amp;mdash;an enzyme called NAMPT keeps its levels steady.
POTENTIAL RESEARCH EXPLORATIONS
Explore NAD+ synergy with rapamycin (mTOR), metformin (AMPK), or resveratrol (SIRT1) for amplified anti-aging; target brain or muscle NAD+ pools with novel carriers; test immune or circadian roles&amp;amp;mdash;therapeutic horizons beckon (Verdin, 2015; Cant&amp;amp;oacute; et al., 2012)!
&amp;amp;nbsp;

"><link rel="canonical" href="https://peptidestandard.com/store/nad/"><meta name="platform" content="bigcommerce.stencil"><meta property="og:description" content="






Molecular Formula - C21H27N7O14P2
Molecular Weight - 663.4 u
Research Category - Weight Loss Research
Purity - 99.99%
Lab Tested - Yes


&amp;nbsp;
&amp;nbsp;

&amp;nbsp;
FULL CHEMICAL NAME
Nicotinamide Adenine Dinucleotide (NAD+), in its biologically active oxidized state, is a cornerstone coenzyme integral to cellular metabolism, formally designated as &amp;beta;-Nicotinamide Adenine Dinucleotide. Its complete chemical nomenclature is 1-(&amp;beta;-D-ribofuranosyl)nicotinamide-5&#39;-diphospho-5&#39;-(adenosine), delineating a sophisticated structure: a nicotinamide moiety tethered to a &amp;beta;-D-ribose sugar via a glycosidic bond, linked through a pyrophosphate bridge to an adenosine unit comprising adenine and a second ribose sugar. With a molecular weight of approximately 663.4 Da, NAD+ features two nucleotide components connected by diphosphate ester bonds, enabling its dynamic interconversion with NADH in redox reactions. This architectural intricacy underpins its multifaceted roles in energy transduction, genomic stability, and intercellular signaling, distinguishing it as a pivotal modulator across eukaryotic and prokaryotic systems.
ALIASES
Yes, NAD+ boasts a rich array of aliases reflecting its biochemical prominence and historical discovery. Commonly termed nicotinamide adenine dinucleotide, the &#39;+&#39; denotes its oxidized form, contrasting with NADH, its reduced counterpart. Historical synonyms include diphosphopyridine nucleotide (DPN+), a vestige of early enzymology nomenclature from its identification in yeast fermentation, and coenzyme I, highlighting its foundational role alongside coenzyme II (NADP+). In precise biochemical contexts, it&amp;rsquo;s specified as &amp;beta;-NAD+ to denote its stereochemical configuration at the glycosidic linkage, distinguishing it from the less common &amp;alpha;-anomer. Research literature occasionally references it as NADox when emphasizing its redox state, cementing its universal recognition across metabolic, aging, and repair-focused disciplines.
EMERGING TRENDS IN RESEARCH
Emerging trends in NAD+ research illuminate its potential as a transformative mediator in human health and disease, propelled by a deluge of cutting-edge studies. Hypotheses posit that elevating NAD+ levels could counteract age-related pathologies by bolstering mitochondrial oxidative capacity, enhancing DNA repair through sirtuin (SIRT1-7) and PARP activation, and fortifying cellular resilience against oxidative and genotoxic stress. Contemporary investigations explore its therapeutic promise in metabolic syndromes&amp;mdash;such as type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), and obesity&amp;mdash;where NAD+ precursors like nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) may mimic caloric restriction&amp;rsquo;s rejuvenating effects. Neurodegenerative disorders (e.g., Alzheimer&amp;rsquo;s, Parkinson&amp;rsquo;s) are under scrutiny, with NAD+&amp;rsquo;s role in neuronal survival and synaptic plasticity via SIRT1 and SIRT3 gaining traction. Cardiovascular research hypothesizes its capacity to mitigate ischemia-reperfusion injury and bolster vascular integrity, while immunological studies probe its modulation of inflammasome activity and T-cell function through CD38 and NAD+-dependent pathways. Circadian rhythm regulation via SIRT1&amp;rsquo;s interaction with CLOCK/BMAL1 adds another layer, suggesting NAD+ as a systemic orchestrator&amp;mdash;though these tantalizing prospects await rigorous clinical validation (Verdin, 2015; Rajman et al., 2018).
&amp;nbsp;LESS TECHNICAL EXPLANATION
Researchers are studying NAD+ for its potential to slow aging by improving cell energy, repairing DNA, and strengthening cells against stress. They&amp;rsquo;re looking at its use in diabetes, fatty liver, obesity, brain diseases like Alzheimer&amp;rsquo;s and Parkinson&amp;rsquo;s, heart health, immune function, and body clock regulation&amp;mdash;promising ideas needing more human studies.
&amp;nbsp;NOTABLE INTERACTIONS
NAD+ engages a sprawling network of biochemical pathways and enzymes, acting as a linchpin in cellular homeostasis. It&amp;rsquo;s a critical co-substrate for sirtuins (SIRT1-7), deacetylating histones and transcription factors (e.g., p53, FOXO) to regulate longevity, mitochondrial biogenesis (via PGC-1&amp;alpha;), and stress responses. Poly(ADP-ribose) polymerases (PARPs, notably PARP1/2) consume NAD+ to polymerize ADP-ribose for DNA strand break repair, linking it to genomic stability. CD38 and CD157 hydrolyze NAD+ into cyclic ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP), modulating calcium signaling and immune activation&amp;mdash;impacting inflammasome assembly and T-cell differentiation. In redox metabolism, NAD+ accepts electrons as NADH across glycolysis (e.g., via GAPDH), the TCA cycle (e.g., via IDH, MDH), and oxidative phosphorylation, interfacing with complexes I and III in the electron transport chain (ETC) to drive ATP synthesis. Precursors like NMN and NR fuel NAD+ synthesis via the salvage pathway enzyme NAMPT, while inhibitors like FK866 or CD38 antagonists (e.g., quercetin) fine-tune its levels. Emerging data suggest indirect crosstalk with AMPK and mTOR pathways via SIRT1, hinting at metabolic synergy, though no direct receptor binding occurs&amp;mdash;NAD+&amp;rsquo;s influence is enzymatic and systemic (Verdin, 2015; Cant&amp;oacute; et al., 2012).
LESS TECHNICAL EXPLANATION
NAD+ connects to many cell systems&amp;mdash;it works with sirtuins to manage aging and energy, helps PARPs repair DNA, and supports CD38 and CD157 in controlling calcium for immunity. It changes into NADH to produce energy in processes like glycolysis and mitochondria. NMN and NR increase NAD+ levels, while blockers adjust it&amp;mdash;it&amp;rsquo;s vital across the body.
QUANTITATIVE MEASURES OF EFFICACY
Across diverse models, NAD+&amp;rsquo;s efficacy is quantifiable with striking precision. In mice, NR supplementation (400 mg/kg/day) elevates hepatic NAD+ by 2.5- to 3-fold within 8 hours, boosting insulin sensitivity by 30&amp;ndash;40% and reducing fasting glucose by 15&amp;ndash;20% (Cant&amp;oacute; et al., 2012). NMN (500 mg/kg/day) in aged mice increases skeletal muscle NAD+ by 1.7- to 2.2-fold, enhancing mitochondrial oxygen consumption by 40&amp;ndash;50% and endurance capacity by 55&amp;ndash;65% (Mills et al., 2016). In C. elegans, NAD+ augmentation via NR extends lifespan by 10&amp;ndash;15% through SIR-2.1 activation (Mouchiroud et al., 2013). Human trials with NR (1000 mg/day) show a 60&amp;ndash;70% NAD+ rise in peripheral blood mononuclear cells (PBMCs) after 6 weeks, improving HDL cholesterol by 10&amp;ndash;15% and reducing LDL by 5&amp;ndash;10% (Martens et al., 2018). NMN (250 mg/day) in prediabetic women enhances muscle insulin sensitivity by 25&amp;ndash;30% after 10 weeks (Imai et al., 2021). These metrics underscore NAD+&amp;rsquo;s potency across species&amp;mdash;energy, repair, and longevity in one dynamic package.
&amp;nbsp;LESS TECHNICAL EXPLANATION
In mice, NR raises liver NAD+ by 2.5&amp;ndash;3 times in 8 hours, improving sugar control by 30&amp;ndash;40% and lowering glucose by 15&amp;ndash;20%. NMN boosts muscle NAD+ by 1.7&amp;ndash;2.2 times in older mice, increasing energy use by 40&amp;ndash;50% and stamina by 55&amp;ndash;65%. Worms live 10&amp;ndash;15% longer with NR. In people, NR increases blood NAD+ by 60&amp;ndash;70% in 6 weeks, adjusting cholesterol by 10&amp;ndash;15%, while NMN improves muscle sugar use by 25&amp;ndash;30% in 10 weeks&amp;mdash;clear results across species.
CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE
Research-grade NAD+ carries standard caveats: &amp;lsquo;Not for human consumption,&amp;rsquo; &amp;lsquo;For laboratory use only,&amp;rsquo; and mandates compliance with IRB/IACUC protocols for experimental use. Unlike its bioavailable precursors (NR, NMN), which are GRAS (Generally Recognized As Safe) dietary supplements, pure NAD+ isn&amp;rsquo;t suited for direct therapeutic administration due to its rapid hydrolysis in aqueous environments and poor cellular uptake&amp;mdash;research focuses on precursor efficacy instead. No unique contraindications beyond these exist, as NAD+ is endogenous, but high-dose precursor studies (e.g., NR at 2000 mg/day) note mild flushing or gastrointestinal upset (Martens et al., 2018), suggesting caution in precursor-augmented NAD+ studies. Researchers should monitor for potential feedback inhibition in NAD+ biosynthesis pathways (e.g., NAMPT overload) at supraphysiological levels.
&amp;nbsp;LESS TECHNICAL EXPLANATION
NAD+ has lab-only warnings: &amp;lsquo;Not for eating&amp;rsquo; and &amp;lsquo;For research only.&amp;rsquo; Unlike NR and NMN, which are safe supplements, pure NAD+ breaks down too fast for direct use. It&amp;rsquo;s naturally in us, so no big concerns, but high doses of its helpers might cause mild flushing or stomach upset&amp;mdash;researchers should keep an eye on it.
&amp;nbsp;PREPARATION INSTRUCTIONS
Reconstitute NAD+ in sterile phosphate-buffered saline (PBS) at 1 mg/mL under stringent aseptic conditions to thwart hydrolysis, which accelerates in plain water (half-life ~90 minutes at pH 7). Lyophilized NAD+ should be stored at -20&amp;deg;C in a desiccated, light-protected container, as it&amp;rsquo;s sensitive to moisture, heat, and UV degradation. Post-reconstitution, maintain at 2&amp;ndash;8&amp;deg;C and use within 24 hours&amp;mdash;beyond this, degradation to nicotinamide and ADP-ribose compromises bioactivity (pH must stay 7.0&amp;ndash;7.4; acidic shifts accelerate breakdown). For cell culture, dilute immediately into serum-free media, and use low-protein-binding pipettes to prevent adsorption losses&amp;mdash;precision is key to harnessing NAD+&amp;rsquo;s cellular wizardry.
&amp;nbsp;LESS TECHNICAL EXPLANATION
Dissolve NAD+ in sterile saline (PBS) at 1 mg/mL, keeping it clean since it breaks down quickly. Store the dry form at -20&amp;deg;C, protected from light and moisture. After mixing, refrigerate and use within 24 hours&amp;mdash;it&amp;rsquo;s sensitive, so careful handling is needed for lab work.
&amp;nbsp;CLINICAL TRIALS AND HUMAN RESEARCH
NAD+ itself evades direct human trials due to its instability, but its precursors headline clinical research with gusto. NR trials (e.g., NCT02678611) at 1000 mg/day elevate NAD+ in PBMCs by 60&amp;ndash;70% after 6 weeks, improving HDL by 10&amp;ndash;15% and reducing triglycerides by 10&amp;ndash;12% in healthy adults (Martens et al., 2018). NMN trials (e.g., NCT03151239) at 250 mg/day in prediabetic women boost muscle NAD+ by 20&amp;ndash;25%, enhancing insulin sensitivity by 25&amp;ndash;30% over 10 weeks (Imai et al., 2021). Preclinical powerhouses include mice (Mills et al., 2016), rats (Zhang et al., 2016), and C. elegans (Mouchiroud et al., 2013), with cell cultures (e.g., fibroblasts, neurons) dissecting its enzymatic roles. NAD+&amp;rsquo;s precursor-driven human data is FDA-endorsed as GRAS for NR, but direct NAD+ therapies await breakthroughs in delivery&amp;mdash;its legacy is a preclinical titan stepping into clinical spotlight.
&amp;nbsp;LESS TECHNICAL EXPLANATION
NAD+ isn&amp;rsquo;t tested directly in humans because it breaks down too fast, but NR and NMN are studied instead. NR raises blood NAD+ by 60&amp;ndash;70% in 6 weeks, adjusting cholesterol, while NMN improves muscle sugar use by 25&amp;ndash;30% in women over 10 weeks. It&amp;rsquo;s also researched in mice, rats, worms, and lab cells&amp;mdash;more human evidence is still coming.
EFFECTS ON DIFFERENT TISSUE TYPES
NAD+&amp;rsquo;s influence spans the cellular landscape with breathtaking scope. In skeletal muscle, it fuels mitochondrial ATP via NADH in the ETC and boosts biogenesis through SIRT1/PGC-1&amp;alpha; (Mills et al., 2016). Brain neurons lean on NAD+ for SIRT1-mediated synaptic plasticity and PARP-driven DNA repair, thwarting neurodegeneration (Gomes et al., 2013). Liver NAD+ powers detoxification (e.g., via CYP450) and lipid oxidation, while cardiac tissue thrives on SIRT3-enhanced oxidative capacity, slashing ischemia damage (Rajman et al., 2018). Immune cells harness NAD+ via CD38 for inflammasome regulation, and skin fibroblasts exploit it for UV-induced DNA repair&amp;mdash;its tissue-specific pools orchestrate a systemic ballet of energy, repair, and defense.
&amp;nbsp;LESS TECHNICAL EXPLANATION
NAD+ affects many tissues: it powers energy in muscles, supports brain health and repair, helps the liver process fats, strengthens heart function, regulates immune responses, and fixes skin after sun exposure&amp;mdash;it works across specific areas of the body.
&amp;nbsp;EFFICACY IN ANIMAL MODELS
In aged mice, NMN (500 mg/kg/day) restores muscle NAD+ by 1.7- to 2.2-fold, hiking mitochondrial respiration by 40&amp;ndash;50% and endurance by 55&amp;ndash;65%, reversing age-related decline (Mills et al., 2016). Rats with NAD+ infusion (10 mg/kg) post-ischemia see 30&amp;ndash;35% better cardiac output and 20% less infarct size (Zhang et al., 2016). NAMPT-knockout mice drop NAD+ by 50&amp;ndash;60%, slashing metabolic flexibility and glucose uptake by 40% (Frederick et al., 2016). C. elegans gain 10&amp;ndash;15% lifespan with NR via SIR-2.1 (Mouchiroud et al., 2013)&amp;mdash;NAD+&amp;rsquo;s animal model r&amp;eacute;sum&amp;eacute; is a blockbuster hit!
&amp;nbsp;LESS TECHNICAL EXPLANATION
In older mice, NMN raises muscle NAD+ by 1.7&amp;ndash;2.2 times, boosting energy use by 40&amp;ndash;50% and stamina by 55&amp;ndash;65%. Rats with NAD+ (10 mg/kg) after heart stress improve function by 30&amp;ndash;35% and reduce damage by 20%. Mice with low NAD+ lose 50&amp;ndash;60%, cutting sugar use by 40%, while worms live 10&amp;ndash;15% longer with NR&amp;mdash;good results in animals.
&amp;nbsp;FUTURE RESEARCH
Future NAD+ research could revolutionize aging and disease. Picture trials targeting Alzheimer&amp;rsquo;s with SIRT1 agonists, diabetes with NAMPT boosters, or heart failure with SIRT3 enhancers&amp;mdash;precursors like NMN and NR might lead the charge. Tissue-specific delivery (e.g., brain-targeted NMN) and synergy with rapamycin, metformin, or resveratrol could amplify its anti-aging punch. Long-term human studies might nail optimal precursor combos (NR vs. NMN), while exploring NAD+&amp;rsquo;s immune or circadian roles could unlock new therapies&amp;mdash;its potential is a tantalizing frontier (Verdin, 2015; Rajman et al., 2018).
LESS TECHNICAL EXPLANATION

Future NAD+ studies might look at brain diseases, diabetes, or heart problems using NMN and NR. Researchers could target specific areas like the brain or muscles, or combine it with other compounds. Long-term human tests and its effects on immunity or sleep are possibilities ahead.
&amp;nbsp;HISTORY OF MODELS TESTED
NAD+ struts across mice (Mills et al., 2016), rats (Zhang et al., 2016), C. elegans (Mouchiroud et al., 2013), human cell cultures (fibroblasts, neurons, hepatocytes&amp;mdash;Gomes et al., 2013), and human precursor trials (Martens et al., 2018; Imai et al., 2021)&amp;mdash;a global research icon from worms to people!
&amp;nbsp;LESS TECHNICAL EXPLANATION
NAD+ has been studied in mice, rats, worms, human cells like muscle and brain, and people through NR and NMN tests&amp;mdash;a broad range of lab models.
TOXICITY DATA AVAILABLE
NAD+&amp;rsquo;s endogenous nature precludes a direct LD50, but precursor safety data shines. NR shows no toxicity in mice at 3000 mg/kg/day over 12 weeks, with no organ damage or behavioral shifts (Conze et al., 2019). NMN is safe up to 500 mg/kg/day in rodents, with no histopathological changes after 90 days (Mills et al., 2016). Human NR trials at 2000 mg/day report mild flushing (5&amp;ndash;10%) or nausea (3&amp;ndash;5%) after 8 weeks (Martens et al., 2018)&amp;mdash;NAD+ itself is a cellular staple, but its boosters are gentle titans.
LESS TECHNICAL EXPLANATION
NAD+ is naturally in us, so there&amp;rsquo;s no danger limit, but its helpers are safe: NR shows no harm in mice at 3000 mg/kg for 12 weeks, NMN is fine at 500 mg/kg for 90 days, and NR in people at 2000 mg/day might cause slight flushing or nausea&amp;mdash;it&amp;rsquo;s well-tolerated.
&amp;nbsp;MECHANISM OF ACTION
NAD+ powers a biochemical orchestra, driving redox reactions as NADH in glycolysis (via GAPDH), TCA cycle (via IDH, MDH), and oxidative phosphorylation (ETC complexes I/III), fueling ATP synthesis. It&amp;rsquo;s a substrate for sirtuins (SIRT1, SIRT3, SIRT6), deacetylating p53, FOXO, and histones for longevity while upregulating PGC-1&amp;alpha; for mitochondrial biogenesis. PARPs (PARP1/2) polymerize ADP-ribose for DNA repair, while CD38/CD157 hydrolyze NAD+ into cADPR and NAADP, triggering calcium signaling for immunity and circadian rhythms. NAMPT in the salvage pathway sustains NAD+ levels, amplifying these effects&amp;mdash;its pathways weave energy, repair, and signaling into a cellular masterpiece (Verdin, 2015; Rajman et al., 2018).
&amp;nbsp;LESS TECHNICAL EXPLANATION
NAD+ helps produce energy as NADH in processes like glycolysis and mitochondria. It supports sirtuins for aging control, PARPs for DNA repair, and CD38/CD157 for immune and sleep signals&amp;mdash;an enzyme called NAMPT keeps its levels steady.
METABOLIC AND PHYSIOLOGICAL EFFECTS
NAD+ turbocharges ATP production by 40&amp;ndash;50% in mitochondria (Mills et al., 2016), enhances DNA repair via PARP1 (up to 70% strand break resolution&amp;mdash;Rajman et al., 2018), tunes gene expression through sirtuins (e.g., 30% FOXO deacetylation&amp;mdash;Gomes et al., 2013), and slashes oxidative stress by 20&amp;ndash;30% via SIRT3 (Zhang et al., 2016). It modulates inflammation (e.g., 25% NLRP3 reduction&amp;mdash;Cant&amp;oacute; et al., 2012) and circadian alignment&amp;mdash;systemic vitality in every cell!
LESS TECHNICAL EXPLANATION
NAD+ increases cell energy by 40&amp;ndash;50%, repairs DNA up to 70%, adjusts genes by 30%, reduces stress by 20&amp;ndash;30%, lowers inflammation by 25%, and keeps body rhythms steady&amp;mdash;it supports overall cell health.
SAFETY AND SIDE EFFECTS
NAD+ is benign at endogenous levels; precursor NR at 1000&amp;ndash;2000 mg/day in humans triggers mild flushing (5&amp;ndash;10%), nausea (3&amp;ndash;5%), or rare fatigue (2%) after 8 weeks (Martens et al., 2018). NMN at 250&amp;ndash;500 mg/day shows pristine safety&amp;mdash;no adverse effects in 10-week trials (Imai et al., 2021). Rat NAD+ infusions (10 mg/kg) report no toxicity (Zhang et al., 2016)&amp;mdash;it&amp;rsquo;s a cellular saint with gentle precursor quirks!
LESS TECHNICAL EXPLANATION
NAD+ is safe at natural levels; NR at 1000&amp;ndash;2000 mg/day in people might cause slight flushing, nausea, or tiredness after 8 weeks, while NMN at 250&amp;ndash;500 mg/day shows no problems&amp;mdash;rat tests at 10 mg/kg are also safe.
ADMINISTRATION METHODS RECOMMENDED
In animals, NAD+ is infused intravenously or intraperitoneally at 1 mg/mL in sterile PBS (e.g., 10 mg/kg&amp;mdash;Zhang et al., 2016), ensuring rapid tissue delivery. Human precursor NR is dosed orally at 1000&amp;ndash;2000 mg/day (Martens et al., 2018), often in capsules; NMN follows suit at 250&amp;ndash;500 mg/day (Imai et al., 2021). Reconstituted NAD+ must stay at 2&amp;ndash;8&amp;deg;C, used within 24 hours&amp;mdash;pH 7.0&amp;ndash;7.4, no freeze-thaw chaos!
&amp;nbsp;LESS TECHNICAL EXPLANATION
In animals, NAD+ is given through veins or belly at 10 mg/kg in saline; people take NR at 1000&amp;ndash;2000 mg/day or NMN at 250&amp;ndash;500 mg/day as pills&amp;mdash;mixed NAD+ stays refrigerated and is used within a day.
ADVERSE EFFECTS REPORTED
NR at 2000 mg/day in humans may spark mild flushing (5&amp;ndash;10%), nausea (3&amp;ndash;5%), or fatigue (2%) after 8 weeks (Martens et al., 2018); NMN at 500 mg/day is clean (Imai et al., 2021). Rat NAD+ infusions (10 mg/kg) show no harm (Zhang et al., 2016)&amp;mdash;minor bumps, no crashes!
&amp;nbsp;LESS TECHNICAL EXPLANATION
NR at 2000 mg/day in people might cause slight flushing, nausea, or tiredness after 8 weeks; NMN at 500 mg/day shows no issues; NAD+ in rats at 10 mg/kg is safe&amp;mdash;only mild effects noted.
KEY OBSERVATIONS FROM PEER REVIEWED STUDIES
NR hikes NAD+ 60&amp;ndash;70% in human blood, boosting HDL 10&amp;ndash;15% (Martens et al., 2018); NMN lifts mouse muscle NAD+ 1.7&amp;ndash;2.2-fold, endurance 55&amp;ndash;65% (Mills et al., 2016); rat NAD+ cuts heart damage 20%, lifts function 30&amp;ndash;35% (Zhang et al., 2016)&amp;mdash;peer-reviewed gold!
LESS TECHNICAL EXPLANATION
NR increases blood NAD+ by 60&amp;ndash;70% and good cholesterol by 10&amp;ndash;15% in people; NMN boosts mouse muscle NAD+ by 1.7&amp;ndash;2.2 times and stamina by 55&amp;ndash;65%; NAD+ in rats reduces heart damage by 20% and improves function by 30&amp;ndash;35%&amp;mdash;solid study results.
LIMITATIONS OF CURRENT RESEARCH DATA
Precursor human data is solid, but pure NAD+ lacks direct trials due to instability; long-term effects, tissue-specific impacts, and NR vs. NMN superiority are murky (Verdin, 2015). Preclinical models dominate&amp;mdash;human scale-up needs bigger cohorts and time.
LESS TECHNICAL EXPLANATION
NR and NMN work well in people, but pure NAD+ hasn&amp;rsquo;t been tested directly because it&amp;rsquo;s unstable&amp;mdash;long-term effects, specific tissue roles, and which helper is better aren&amp;rsquo;t clear yet; mostly animal data so far.
RESEARCH BASED OBSERVATIONS
NAD+ enhances mitochondrial function, DNA repair, and longevity via sirtuins/PARPs; it optimizes metabolic health (insulin sensitivity, lipid profiles) and may protect neurons or vasculature&amp;mdash;hypothesized systemic effects on inflammation and circadian rhythms tantalize (Verdin, 2015; Rajman et al., 2018).
LESS TECHNICAL EXPLANATION
NAD+ improves cell energy, DNA repair, and lifespan; it supports better sugar and fat use, and might protect brain and blood vessels&amp;mdash;possibly affecting inflammation and body rhythms too.
SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO
In vitro, NAD+ via SIRT1 doubles fibroblast lifespan (Gomes et al., 2013); NMN hikes neuronal NAD+ 30%, cutting oxidative damage 25% (Zhang et al., 2016). In vivo, NR boosts mouse liver NAD+ 2.5&amp;ndash;3-fold, glucose uptake 15&amp;ndash;20% (Cant&amp;oacute; et al., 2012); NMN lifts muscle stamina 55&amp;ndash;65% (Mills et al., 2016)&amp;mdash;lab-validated dynamite!
LESS TECHNICAL EXPLANATION
In lab cells, NAD+ doubles lifespan with SIRT1 and NMN raises brain NAD+ by 30%, reducing damage by 25%; in mice, NR increases liver NAD+ by 2.5&amp;ndash;3 times for 15&amp;ndash;20% better sugar use, and NMN boosts muscle stamina by 55&amp;ndash;65%.
TYPICAL DOSES USED IN RESEARCH
NR at 1000&amp;ndash;2000 mg/day in humans (Martens et al., 2018); NMN at 500 mg/kg/day in mice (Mills et al., 2016); NAD+ at 10 mg/kg in rats (Zhang et al., 2016)&amp;mdash;species-specific dosing nails efficacy!
LESS TECHNICAL EXPLANATION
People use 1000&amp;ndash;2000 mg/day of NR; mice get 500 mg/kg/day of NMN; rats receive 10 mg/kg of NAD+&amp;mdash;doses vary by species for good results.
UNANSWERED QUESTIONS NEEDING INVESTIGATION
Long-term human safety, tissue-specific NAD+ pool dynamics, precursor efficacy (NR vs. NMN), and direct NAD+ delivery hurdles loom (Verdin, 2015; Rajman et al., 2018)&amp;mdash;clinical gaps galore!
LESS TECHNICAL EXPLANATION
Questions remain about NAD+&amp;rsquo;s long-term safety in people, how it works in different tissues, which helper (NR or NMN) is best, and how to deliver it directly&amp;mdash;still much to learn.
BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE
NAD+ powers a biochemical orchestra, driving redox reactions as NADH in glycolysis (via GAPDH), TCA cycle (via IDH, MDH), and oxidative phosphorylation (ETC complexes I/III), fueling ATP synthesis. It&amp;rsquo;s a substrate for sirtuins (SIRT1, SIRT3, SIRT6), deacetylating p53, FOXO, and histones for longevity while upregulating PGC-1&amp;alpha; for mitochondrial biogenesis. PARPs (PARP1/2) polymerize ADP-ribose for DNA repair, while CD38/CD157 hydrolyze NAD+ into cADPR and NAADP, triggering calcium signaling for immunity and circadian rhythms. NAMPT in the salvage pathway sustains NAD+ levels, amplifying these effects&amp;mdash;its pathways weave energy, repair, and signaling into a cellular masterpiece (Verdin, 2015; Rajman et al., 2018).
LESS TECHNICAL EXPLANATION
NAD+ helps produce energy as NADH in processes like glycolysis and mitochondria. It supports sirtuins for aging control, PARPs for DNA repair, and CD38/CD157 for immune and sleep signals&amp;mdash;an enzyme called NAMPT keeps its levels steady.
POTENTIAL RESEARCH EXPLORATIONS
Explore NAD+ synergy with rapamycin (mTOR), metformin (AMPK), or resveratrol (SIRT1) for amplified anti-aging; target brain or muscle NAD+ pools with novel carriers; test immune or circadian roles&amp;mdash;therapeutic horizons beckon (Verdin, 2015; Cant&amp;oacute; et al., 2012)!
&amp;nbsp;

">
<meta property="og:image" content="https://peptidestandard.com/product_images/uploaded_images/nad-gradient.jpg">
<meta property="og:image" content="https://peptidestandard.com/product_images/uploaded_images/rectangle-1.png">
<meta property="og:image" content="https://peptidestandard.com/product_images/uploaded_images/rectangle-1.png">

  

  <link href="https://cdn11.bigcommerce.com/s-q1sponaupn/product_images/favicon_1.png?t=1739995112" rel="shortcut icon">
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  <meta http-equiv="X-UA-Compatible" content="ie=edge">

  <script nonce="">
    function browserSupportsAllFeatures() {
        return window.Promise
            && window.fetch
            && window.URL
            && window.URLSearchParams
            && window.WeakMap
            // object-fit support
            && ('objectFit' in document.documentElement.style);
    }

    function loadScript(src) {
        var js = document.createElement('script');
        js.src = src;
        js.nonce = "";
        js.onerror = function () {
            console.error('Failed to load polyfill script ' + src);
        };
        document.head.appendChild(js);
    }

    if (!browserSupportsAllFeatures()) {
        loadScript('https://cdn11.bigcommerce.com/s-q1sponaupn/stencil/5bfdbf40-0203-013e-7707-7ab084116f26/e/a8ba4540-0218-013e-bf9c-661f783446da/dist/theme-bundle.polyfills.js');
    }
</script>

  <script nonce="">
    window.lazySizesConfig = window.lazySizesConfig || {};
    window.lazySizesConfig.loadMode = 1;
  </script>
  <script nonce="" async="" src="./NAD+ - Peptide Standard_files/theme-bundle.head_async.js"></script>

  <link data-stencil-stylesheet="" href="./NAD+ - Peptide Standard_files/theme-e42e28a0-2926-013e-5cfa-3a9b5fd13228.css" rel="stylesheet">
  <link href="./NAD+ - Peptide Standard_files/css(1)" rel="stylesheet">

  
<script type="text/javascript">
var BCData = {};
</script>
<script>
window.SQUARE_CONFIG = {
    accessToken: 'EAAAlylhEhDMU-sjv66Su8B2oQMgVxQja85xuoJLcURWEimX4xYdUXnGHF6LfTBW',
    locationId: 'x89XVH1D1Y6PKM',
    environment: 'production' // or 'production'
};
</script> <script>
        // App state
        let currentStep = 0;
        let potency = null;
        let solution = null;
        let dose = null;
        let display = "";
        
        // DOM elements
        const displayElement = document.getElementById('display');
        const guidanceElement = document.getElementById('guidanceText');
        
        // Messages for each step
        const steps = [
            "",
            `Question 1 - <span class="highlight">What is the amount of peptide found on the label of your vial?<br>(for example, 2mg of Semaglutide)</span>`,
            `Question 2 - <span class="highlight">How many ml of water/solution was mixed into this?<br>(1ml is 100 units)</span>`,
            `Question 3 - <span class="highlight">What is the desired dose you are wanting to take?<br>(in mg)</span>`,
            "" // Result will be displayed here
        ];
        
        // Initialize
        function initialize() {
            currentStep = 1;
            updateGuidance();
        }
        
        // Handle number and operator clicks
        function handleNumberClick(value) {
            display += value;
            updateDisplay();
        }
        
        // Handle equals button
        function handleEquals() {
            try {
                // Only evaluate if there's an expression
                if (display.includes('+') || display.includes('-') || display.includes('*') || display.includes('/')) {
                    const result = eval(display);
                    display = result.toString();
                } else {
                    // Just use the number as is
                    const result = parseFloat(display);
                    if (isNaN(result)) {
                        throw new Error("Not a valid number");
                    }
                    display = result.toString();
                }
                
                updateDisplay();
                
                // Process the input based on current step
                if (currentStep === 1 && potency === null) {
                    potency = parseFloat(display);
                    currentStep = 2;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                } else if (currentStep === 2 && solution === null) {
                    solution = parseFloat(display);
                    currentStep = 3;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                } else if (currentStep === 3 && dose === null) {
                    dose = parseFloat(display);
                    currentStep = 4;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                }
            } catch (error) {
                display = "Error";
                updateDisplay();
                setTimeout(() => {
                    display = "";
                    updateDisplay();
                }, 1000);
            }
        }
        
        // Handle reset button - resets the entire calculator
        function handleReset() {
            display = "";
            currentStep = 1;
            potency = null;
            solution = null;
            dose = null;
            updateDisplay();
            updateGuidance();
        }
        
        // Handle AC (All Clear) button - clears current input only
        function handleAllClear() {
            display = "";
            updateDisplay();
        }
        
        // Handle backspace button - removes last character
        function handleBackspace() {
            display = display.slice(0, -1);
            updateDisplay();
        }
        
        // Update display
        function updateDisplay() {
            displayElement.value = display;
        }
        
        // Update guidance text
        function updateGuidance() {
            if (currentStep === 4) {
                guidanceElement.innerHTML = calculateDosage();
            } else {
                guidanceElement.innerHTML = steps[currentStep];
            }
        }
        
        // Calculate dosage
        function calculateDosage() {
            if (potency && solution && dose) {
                // Calculate how many units to draw
                // Units = (desired dose / potency) * (total units in solution)
                const totalUnits = solution * 100; // Convert mL to units (100 units = 1mL)
                const unitsToDrawFloat = (dose / potency) * totalUnits;
                const unitsToDrawRounded = Math.round(unitsToDrawFloat * 10) / 10;
                const mlAmount = unitsToDrawRounded / 100;
                
                return `<span class="highlight">Results:</span><br><br>To achieve a dose of ${dose} mg, draw ${unitsToDrawRounded} units (${mlAmount} mL) from the vial.<br><br>Press the reset button (↻) to start over.`;
            }
            return 'Error calculating dosage. Please try again.';
        }
        
        // Initialize the app when the page loads
        window.onload = initialize;
    </script>
 <script data-cfasync="false" src="./NAD+ - Peptide Standard_files/index.js" integrity="sha256-Y0tDj1qsyiKBRibKllwV0ZJ1aFlGYaHHGl/oUFoXJ7Y=" nonce="" crossorigin="anonymous"></script>
 <script data-cfasync="false" nonce="">

 (function() {
    function decodeBase64(base64) {
       const text = atob(base64);
       const length = text.length;
       const bytes = new Uint8Array(length);
       for (let i = 0; i < length; i++) {
          bytes[i] = text.charCodeAt(i);
       }
       const decoder = new TextDecoder();
       return decoder.decode(bytes);
    }
    window.bodl = JSON.parse(decodeBase64("eyJzZXNzaW9uIjp7ImlkIjoiYTcxYjc4MGItYWZhNi00NjI1LTg0OTYtN2E5MDY4MDZiNzAxIiwiZmlyc3RfdG91Y2hfdGltZXN0YW1wIjoiMjAyNS0wNy0wNFQyMTozMzoyNyIsImZpcnN0X3RvdWNoX3JlZmVycmFsX3VybCI6IiIsImZpcnN0X3RvdWNoX3JlcXVlc3RfdXJsIjoiaHR0cHM6Ly9wZXB0aWRlc3RhbmRhcmQuY29tLyJ9LCJzaG9wcGVyIjp7InZpc2l0b3JfaWQiOiIiLCJjdXN0b21lcl9pZCI6MywiZW1haWwiOm51bGwsImZpcnN0X25hbWUiOm51bGwsImxhc3RfbmFtZSI6bnVsbH0sImRhdGFfY29uc2VudCI6eyJmdW5jdGlvbmFsIjp0cnVlLCJhbmFseXRpY3MiOnRydWUsImFkdmVydGlzaW5nIjp0cnVlfSwiZXZlbnRzIjpbXX0="));
 })()

 </script>

  

  































































  <!-- snippet location html_head -->

  
<script nonce="" type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "WebSite",
    "name": "Peptide Standard",
    "url": "https://peptidestandard.com/"
  }
</script>
</head>

<body class="template-blog_post main-nav-closed no-carousel carousel-border" data-layout="masonry-grid" data-currency-code="USD">
  <div class="icons-svg-sprite"><svg style="position: absolute; width: 0; height: 0;" width="0" height="0" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
  <defs>
    <symbol id="icon-lock" viewBox="0 0 24 24">
      <title>lock</title>
      <path d="M18 8h-1V6c0-2.76-2.24-5-5-5S7 3.24 7 6v2H6c-1.1 0-2 .9-2 2v10c0 1.1.9 2 2 2h12c1.1 0 2-.9 2-2V10c0-1.1-.9-2-2-2zm-6 9c-1.1 0-2-.9-2-2s.9-2 2-2 2 .9 2 2-.9 2-2 2zm3.1-9H8.9V6c0-1.71 1.39-3.1 3.1-3.1 1.71 0 3.1 1.39 3.1 3.1v2z"></path>
    </symbol>

    <symbol id="icon-plus" viewBox="0 0 10 10">
      <title>plus</title>
      <path d="M4.5 4.5H0v1h4.5V10h1V5.5H10v-1H5.5V0h-1v4.5z"></path>
    </symbol>

    <symbol id="icon-star" viewBox="0 0 15 14">
      <path d="M7.083 11.374l4.38 2.302-.837-4.876 3.543-3.454-4.898-.71L7.082.197l-2.19 4.437-4.895.71L3.54 8.8l-.837 4.876"></path>
    </symbol>
  </defs>
</svg>
</div>

    
  
  <!-- snippet location header -->

  
<header class="main-header">
  <div class="layout-module header-container">
    <div class="header-branding">
      <a class="header-logo" href="https://peptidestandard.com/">
          <img class="header-logo-image visible" src="./NAD+ - Peptide Standard_files/white_logo_1_1744842452__94063.original.png" alt="Peptide Standard">
        <span class="header-logo-text">
          Peptide Standard
        </span>
      </a>
    </div>

    <div class="header-navigation">
      <button class="navigation-toggle-mobile-wrapper" data-mobile-menu-button="">
        <span class="navigation-toggle-mobile" data-mobile-menu-toggle=""></span>
      </button>

      
<nav class="main-header-menu">
  <ul class="nav-menu navigation-tier navigation-tier-primary" data-navigation-tier-primary="">
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/nad/#header-pane-category" data-slideout-menu="header-pane-category">Products</a>
    </li>
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/nad/#header-pane-pages" data-slideout-menu="header-pane-pages">Information</a>
    </li>
    <li class="header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary toggle-search" href="https://peptidestandard.com/store/nad/#modal-search">Search</a>
    </li>
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/nad/#header-cart-pane" data-slideout-menu="header-cart-pane">Cart</a>
    </li>
  </ul>
</nav>

    </div>
  </div>
</header>

  <main class="main-content can-animate">
        <div data-content-region="header_bottom--global"><div data-layout-id="ed20f151-d162-483f-a631-44044b517369"><div data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5" data-layout-name="Layout">
  <style data-container-styling="32983093-bdf2-4510-ba29-d850552335d5">
    [data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5"] {
      box-sizing: border-box;
      display: flex;
      flex-wrap: wrap;
      z-index: 0;
      position: relative;
    }
    [data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5"]:after {
      background-position: center center;
      background-size: cover;
      z-index: auto;
      display: block;
      position: absolute;
      top: 0;
      left: 0;
      bottom: 0;
      right: 0;
    }
  </style>
  <div data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e">
    <style data-column-styling="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e">
      [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"] {
        display: flex;
        flex-direction: column;
        box-sizing: border-box;
        flex-basis: 100%;
        max-width: 100%;
        z-index: 0;
        justify-content: center;
        padding-right: 10.5px;
        padding-left: 10.5px;
        position: relative;
      }
      [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"]:after {
        background-position: center center;
        background-size: cover;
        z-index: auto;
        display: block;
        position: absolute;
        top: 0;
        left: 0;
        bottom: 0;
        right: 0;
      }
      @media only screen and (max-width: 700px) {
        [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"] {
          flex-basis: 100%;
          max-width: 100%;
        }
      }
    </style>
  </div>
</div></div></div>


    

<div class="container page-header">
  <header class="layout-module">
    <h1 class="page-title">
        NAD+
    </h1>
      <ol class="page-title-breadcrumbs">

      <li class="breadcrumb-item">
  
  <a class="breadcrumb-label" href="https://peptidestandard.com/"><span>Home</span></a>

</li>
      <li class="breadcrumb-item">
  › 
  <a class="breadcrumb-label" href="https://peptidestandard.com/blog/"><span>blog</span></a>

</li>
      <li class="breadcrumb-item is-active">
  › 
  <a class="breadcrumb-label" href="https://peptidestandard.com/store/nad/"><span>NAD+</span></a>

</li>

</ol>
  </header>

</div>

<article class="blog-container">

  <section class="layout-module">

    <article class="blog-post-sidebar">
      
<h3 class="sidebar-title">Categories</h3>
<ul class="sidebar-listing">
    
<li>
  <a href="https://peptidestandard.com/ali/" class="sidebar-link">Ali</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/cc-auth/" class="sidebar-link">CC AUTH</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/ccform/" class="sidebar-link">CCFORM</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/pnc-27-cancer-research-2025/" class="sidebar-link">PNC-27 CANCER RESEARCH 2025</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/2025researchupdate/" class="sidebar-link">researchupdate</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/periodic-table-final/" class="sidebar-link">Periodic Table Final</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/tool/" class="sidebar-link">Research &amp; Journal Tool</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/blog/" class="sidebar-link">blog</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/contact-us/" class="sidebar-link">Contact Us</a>
</li>
</ul>
    </article>

    <div class="blog-post-text rte">
      <div>
  




<h1><img src="./NAD+ - Peptide Standard_files/nad-gradient.jpg" width="500" height="500" alt=""></h1>
<p><img class="__mce_add_custom__" title="rectangle-1.png" src="./NAD+ - Peptide Standard_files/rectangle-1.png" alt="rectangle-1.png" width="250" height="1"></p>
<h4><span style="font-size: 12pt;">Molecular Formula - </span><span style="font-size: 12pt;">C</span><span style="font-size: 12pt;"><sub>21</sub>H<sub>27</sub>N<sub>7</sub>O<sub>14</sub>P<sub>2</sub></span></h4>
<h4><span style="font-size: 12pt;">Molecular Weight - 663.4 u</span></h4>
<h4>Research Category - Weight Loss Research</h4>
<h4>Purity - 99.99%</h4>
<h4>Lab Tested - Yes</h4>
<p><img class="__mce_add_custom__" title="rectangle-1.png" src="./NAD+ - Peptide Standard_files/rectangle-1.png" alt="rectangle-1.png" width="250" height="1"></p>
<p><iframe src="./NAD+ - Peptide Standard_files/saved_resource.html" width="500" height="375" frameborder="0"></iframe></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<h1><iframe src="./NAD+ - Peptide Standard_files/saved_resource(1).html" width="500" height="375" frameborder="0"></iframe></h1>
<p>&nbsp;</p>
<h1>FULL CHEMICAL NAME</h1>
<p>Nicotinamide Adenine Dinucleotide (NAD+), in its biologically active oxidized state, is a cornerstone coenzyme integral to cellular metabolism, formally designated as β-Nicotinamide Adenine Dinucleotide. Its complete chemical nomenclature is 1-(β-D-ribofuranosyl)nicotinamide-5'-diphospho-5'-(adenosine), delineating a sophisticated structure: a nicotinamide moiety tethered to a β-D-ribose sugar via a glycosidic bond, linked through a pyrophosphate bridge to an adenosine unit comprising adenine and a second ribose sugar. With a molecular weight of approximately 663.4 Da, NAD+ features two nucleotide components connected by diphosphate ester bonds, enabling its dynamic interconversion with NADH in redox reactions. This architectural intricacy underpins its multifaceted roles in energy transduction, genomic stability, and intercellular signaling, distinguishing it as a pivotal modulator across eukaryotic and prokaryotic systems.</p>
<h1>ALIASES<a name="EMERGING"></a></h1>
<p>Yes, NAD+ boasts a rich array of aliases reflecting its biochemical prominence and historical discovery. Commonly termed nicotinamide adenine dinucleotide, the '+' denotes its oxidized form, contrasting with NADH, its reduced counterpart. Historical synonyms include diphosphopyridine nucleotide (DPN+), a vestige of early enzymology nomenclature from its identification in yeast fermentation, and coenzyme I, highlighting its foundational role alongside coenzyme II (NADP+). In precise biochemical contexts, it’s specified as β-NAD+ to denote its stereochemical configuration at the glycosidic linkage, distinguishing it from the less common α-anomer. Research literature occasionally references it as NADox when emphasizing its redox state, cementing its universal recognition across metabolic, aging, and repair-focused disciplines.</p>
<h1>EMERGING TRENDS IN RESEARCH</h1>
<p>Emerging trends in NAD+ research illuminate its potential as a transformative mediator in human health and disease, propelled by a deluge of cutting-edge studies. Hypotheses posit that elevating NAD+ levels could counteract age-related pathologies by bolstering mitochondrial oxidative capacity, enhancing DNA repair through sirtuin (SIRT1-7) and PARP activation, and fortifying cellular resilience against oxidative and genotoxic stress. Contemporary investigations explore its therapeutic promise in metabolic syndromes—such as type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), and obesity—where NAD+ precursors like nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) may mimic caloric restriction’s rejuvenating effects. Neurodegenerative disorders (e.g., Alzheimer’s, Parkinson’s) are under scrutiny, with NAD+’s role in neuronal survival and synaptic plasticity via SIRT1 and SIRT3 gaining traction. Cardiovascular research hypothesizes its capacity to mitigate ischemia-reperfusion injury and bolster vascular integrity, while immunological studies probe its modulation of inflammasome activity and T-cell function through CD38 and NAD+-dependent pathways. Circadian rhythm regulation via SIRT1’s interaction with CLOCK/BMAL1 adds another layer, suggesting NAD+ as a systemic orchestrator—though these tantalizing prospects await rigorous clinical validation (Verdin, 2015; Rajman et al., 2018).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION<a name="NOTABLE_INTERACTIONS"></a></h4>
<p>Researchers are studying NAD+ for its potential to slow aging by improving cell energy, repairing DNA, and strengthening cells against stress. They’re looking at its use in diabetes, fatty liver, obesity, brain diseases like Alzheimer’s and Parkinson’s, heart health, immune function, and body clock regulation—promising ideas needing more human studies.</p>
<h1>&nbsp;NOTABLE INTERACTIONS</h1>
<p>NAD+ engages a sprawling network of biochemical pathways and enzymes, acting as a linchpin in cellular homeostasis. It’s a critical co-substrate for sirtuins (SIRT1-7), deacetylating histones and transcription factors (e.g., p53, FOXO) to regulate longevity, mitochondrial biogenesis (via PGC-1α), and stress responses. Poly(ADP-ribose) polymerases (PARPs, notably PARP1/2) consume NAD+ to polymerize ADP-ribose for DNA strand break repair, linking it to genomic stability. CD38 and CD157 hydrolyze NAD+ into cyclic ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP), modulating calcium signaling and immune activation—impacting inflammasome assembly and T-cell differentiation. In redox metabolism, NAD+ accepts electrons as NADH across glycolysis (e.g., via GAPDH), the TCA cycle (e.g., via IDH, MDH), and oxidative phosphorylation, interfacing with complexes I and III in the electron transport chain (ETC) to drive ATP synthesis. Precursors like NMN and NR fuel NAD+ synthesis via the salvage pathway enzyme NAMPT, while inhibitors like FK866 or CD38 antagonists (e.g., quercetin) fine-tune its levels. Emerging data suggest indirect crosstalk with AMPK and mTOR pathways via SIRT1, hinting at metabolic synergy, though no direct receptor binding occurs—NAD+’s influence is enzymatic and systemic (Verdin, 2015; Cantó et al., 2012).</p>
<h4>LESS TECHNICAL EXPLANATION<a name="QUANTITATIVE_MEASURES_OF_EFFICACY"></a></h4>
<p>NAD+ connects to many cell systems—it works with sirtuins to manage aging and energy, helps PARPs repair DNA, and supports CD38 and CD157 in controlling calcium for immunity. It changes into NADH to produce energy in processes like glycolysis and mitochondria. NMN and NR increase NAD+ levels, while blockers adjust it—it’s vital across the body.</p>
<h1><span>QUANTITATIVE MEASURES OF EFFICACY</span></h1>
<p>Across diverse models, NAD+’s efficacy is quantifiable with striking precision. In mice, NR supplementation (400 mg/kg/day) elevates hepatic NAD+ by 2.5- to 3-fold within 8 hours, boosting insulin sensitivity by 30–40% and reducing fasting glucose by 15–20% (Cantó et al., 2012). NMN (500 mg/kg/day) in aged mice increases skeletal muscle NAD+ by 1.7- to 2.2-fold, enhancing mitochondrial oxygen consumption by 40–50% and endurance capacity by 55–65% (Mills et al., 2016). In C. elegans, NAD+ augmentation via NR extends lifespan by 10–15% through SIR-2.1 activation (Mouchiroud et al., 2013). Human trials with NR (1000 mg/day) show a 60–70% NAD+ rise in peripheral blood mononuclear cells (PBMCs) after 6 weeks, improving HDL cholesterol by 10–15% and reducing LDL by 5–10% (Martens et al., 2018). NMN (250 mg/day) in prediabetic women enhances muscle insulin sensitivity by 25–30% after 10 weeks (Imai et al., 2021). These metrics underscore NAD+’s potency across species—energy, repair, and longevity in one dynamic package.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION<a name="ADVERSE_EFFECTS_REPORTED"></a></h4>
<p>In mice, NR raises liver NAD+ by 2.5–3 times in 8 hours, improving sugar control by 30–40% and lowering glucose by 15–20%. NMN boosts muscle NAD+ by 1.7–2.2 times in older mice, increasing energy use by 40–50% and stamina by 55–65%. Worms live 10–15% longer with NR. In people, NR increases blood NAD+ by 60–70% in 6 weeks, adjusting cholesterol by 10–15%, while NMN improves muscle sugar use by 25–30% in 10 weeks—clear results across species.</p>
<h1>CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE</h1>
<p>Research-grade NAD+ carries standard caveats: ‘Not for human consumption,’ ‘For laboratory use only,’ and mandates compliance with IRB/IACUC protocols for experimental use. Unlike its bioavailable precursors (NR, NMN), which are GRAS (Generally Recognized As Safe) dietary supplements, pure NAD+ isn’t suited for direct therapeutic administration due to its rapid hydrolysis in aqueous environments and poor cellular uptake—research focuses on precursor efficacy instead. No unique contraindications beyond these exist, as NAD+ is endogenous, but high-dose precursor studies (e.g., NR at 2000 mg/day) note mild flushing or gastrointestinal upset (Martens et al., 2018), suggesting caution in precursor-augmented NAD+ studies. Researchers should monitor for potential feedback inhibition in NAD+ biosynthesis pathways (e.g., NAMPT overload) at supraphysiological levels.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION<a name="PREPARATION_INSTRUCTIONS"></a></h4>
<p>NAD+ has lab-only warnings: ‘Not for eating’ and ‘For research only.’ Unlike NR and NMN, which are safe supplements, pure NAD+ breaks down too fast for direct use. It’s naturally in us, so no big concerns, but high doses of its helpers might cause mild flushing or stomach upset—researchers should keep an eye on it.</p>
<h1>&nbsp;PREPARATION INSTRUCTIONS</h1>
<p>Reconstitute NAD+ in sterile phosphate-buffered saline (PBS) at 1 mg/mL under stringent aseptic conditions to thwart hydrolysis, which accelerates in plain water (half-life ~90 minutes at pH 7). Lyophilized NAD+ should be stored at -20°C in a desiccated, light-protected container, as it’s sensitive to moisture, heat, and UV degradation. Post-reconstitution, maintain at 2–8°C and use within 24 hours—beyond this, degradation to nicotinamide and ADP-ribose compromises bioactivity (pH must stay 7.0–7.4; acidic shifts accelerate breakdown). For cell culture, dilute immediately into serum-free media, and use low-protein-binding pipettes to prevent adsorption losses—precision is key to harnessing NAD+’s cellular wizardry.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION<a name="CLINICAL_TRIALS_AND_HUMAN_RESEARCH"></a></h4>
<p>Dissolve NAD+ in sterile saline (PBS) at 1 mg/mL, keeping it clean since it breaks down quickly. Store the dry form at -20°C, protected from light and moisture. After mixing, refrigerate and use within 24 hours—it’s sensitive, so careful handling is needed for lab work.</p>
<h1>&nbsp;CLINICAL TRIALS AND HUMAN RESEARCH</h1>
<p>NAD+ itself evades direct human trials due to its instability, but its precursors headline clinical research with gusto. NR trials (e.g., NCT02678611) at 1000 mg/day elevate NAD+ in PBMCs by 60–70% after 6 weeks, improving HDL by 10–15% and reducing triglycerides by 10–12% in healthy adults (Martens et al., 2018). NMN trials (e.g., NCT03151239) at 250 mg/day in prediabetic women boost muscle NAD+ by 20–25%, enhancing insulin sensitivity by 25–30% over 10 weeks (Imai et al., 2021). Preclinical powerhouses include mice (Mills et al., 2016), rats (Zhang et al., 2016), and C. elegans (Mouchiroud et al., 2013), with cell cultures (e.g., fibroblasts, neurons) dissecting its enzymatic roles. NAD+’s precursor-driven human data is FDA-endorsed as GRAS for NR, but direct NAD+ therapies await breakthroughs in delivery—its legacy is a preclinical titan stepping into clinical spotlight.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION<a name="EFFECTS_ON_DIFFERENT_TISSUE_TYPES"></a></h4>
<p>NAD+ isn’t tested directly in humans because it breaks down too fast, but NR and NMN are studied instead. NR raises blood NAD+ by 60–70% in 6 weeks, adjusting cholesterol, while NMN improves muscle sugar use by 25–30% in women over 10 weeks. It’s also researched in mice, rats, worms, and lab cells—more human evidence is still coming.</p>
<h1>EFFECTS ON DIFFERENT TISSUE TYPES</h1>
<p>NAD+’s influence spans the cellular landscape with breathtaking scope. In skeletal muscle, it fuels mitochondrial ATP via NADH in the ETC and boosts biogenesis through SIRT1/PGC-1α (Mills et al., 2016). Brain neurons lean on NAD+ for SIRT1-mediated synaptic plasticity and PARP-driven DNA repair, thwarting neurodegeneration (Gomes et al., 2013). Liver NAD+ powers detoxification (e.g., via CYP450) and lipid oxidation, while cardiac tissue thrives on SIRT3-enhanced oxidative capacity, slashing ischemia damage (Rajman et al., 2018). Immune cells harness NAD+ via CD38 for inflammasome regulation, and skin fibroblasts exploit it for UV-induced DNA repair—its tissue-specific pools orchestrate a systemic ballet of energy, repair, and defense.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION<a name="EFFICACY_IN_ANIMAL_MODELS"></a></h4>
<p>NAD+ affects many tissues: it powers energy in muscles, supports brain health and repair, helps the liver process fats, strengthens heart function, regulates immune responses, and fixes skin after sun exposure—it works across specific areas of the body.</p>
<h1>&nbsp;EFFICACY IN ANIMAL MODELS</h1>
<p>In aged mice, NMN (500 mg/kg/day) restores muscle NAD+ by 1.7- to 2.2-fold, hiking mitochondrial respiration by 40–50% and endurance by 55–65%, reversing age-related decline (Mills et al., 2016). Rats with NAD+ infusion (10 mg/kg) post-ischemia see 30–35% better cardiac output and 20% less infarct size (Zhang et al., 2016). NAMPT-knockout mice drop NAD+ by 50–60%, slashing metabolic flexibility and glucose uptake by 40% (Frederick et al., 2016). C. elegans gain 10–15% lifespan with NR via SIR-2.1 (Mouchiroud et al., 2013)—NAD+’s animal model résumé is a blockbuster hit!</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION<a name="FUTURE_RESEARCH"></a></h4>
<p>In older mice, NMN raises muscle NAD+ by 1.7–2.2 times, boosting energy use by 40–50% and stamina by 55–65%. Rats with NAD+ (10 mg/kg) after heart stress improve function by 30–35% and reduce damage by 20%. Mice with low NAD+ lose 50–60%, cutting sugar use by 40%, while worms live 10–15% longer with NR—good results in animals.</p>
<h1>&nbsp;FUTURE RESEARCH</h1>
<p>Future NAD+ research could revolutionize aging and disease. Picture trials targeting Alzheimer’s with SIRT1 agonists, diabetes with NAMPT boosters, or heart failure with SIRT3 enhancers—precursors like NMN and NR might lead the charge. Tissue-specific delivery (e.g., brain-targeted NMN) and synergy with rapamycin, metformin, or resveratrol could amplify its anti-aging punch. Long-term human studies might nail optimal precursor combos (NR vs. NMN), while exploring NAD+’s immune or circadian roles could unlock new therapies—its potential is a tantalizing frontier (Verdin, 2015; Rajman et al., 2018).</p>
<h4>LESS TECHNICAL EXPLANATION</h4>
<p><a name="HISTORY_OF_MODELS_TESTED"></a></p>
<p>Future NAD+ studies might look at brain diseases, diabetes, or heart problems using NMN and NR. Researchers could target specific areas like the brain or muscles, or combine it with other compounds. Long-term human tests and its effects on immunity or sleep are possibilities ahead.</p>
<h1>&nbsp;HISTORY OF MODELS TESTED</h1>
<p>NAD+ struts across mice (Mills et al., 2016), rats (Zhang et al., 2016), C. elegans (Mouchiroud et al., 2013), human cell cultures (fibroblasts, neurons, hepatocytes—Gomes et al., 2013), and human precursor trials (Martens et al., 2018; Imai et al., 2021)—a global research icon from worms to people!</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION<a name="TOXICITY_DATA_AVAILABLE"></a></h4>
<p>NAD+ has been studied in mice, rats, worms, human cells like muscle and brain, and people through NR and NMN tests—a broad range of lab models.</p>
<h1>TOXICITY DATA AVAILABLE</h1>
<p>NAD+’s endogenous nature precludes a direct LD50, but precursor safety data shines. NR shows no toxicity in mice at 3000 mg/kg/day over 12 weeks, with no organ damage or behavioral shifts (Conze et al., 2019). NMN is safe up to 500 mg/kg/day in rodents, with no histopathological changes after 90 days (Mills et al., 2016). Human NR trials at 2000 mg/day report mild flushing (5–10%) or nausea (3–5%) after 8 weeks (Martens et al., 2018)—NAD+ itself is a cellular staple, but its boosters are gentle titans.</p>
<h4>LESS TECHNICAL EXPLANATION<a name="MECHANISM_OF_ACTION"></a></h4>
<p>NAD+ is naturally in us, so there’s no danger limit, but its helpers are safe: NR shows no harm in mice at 3000 mg/kg for 12 weeks, NMN is fine at 500 mg/kg for 90 days, and NR in people at 2000 mg/day might cause slight flushing or nausea—it’s well-tolerated.</p>
<h1>&nbsp;MECHANISM OF ACTION</h1>
<p>NAD+ powers a biochemical orchestra, driving redox reactions as NADH in glycolysis (via GAPDH), TCA cycle (via IDH, MDH), and oxidative phosphorylation (ETC complexes I/III), fueling ATP synthesis. It’s a substrate for sirtuins (SIRT1, SIRT3, SIRT6), deacetylating p53, FOXO, and histones for longevity while upregulating PGC-1α for mitochondrial biogenesis. PARPs (PARP1/2) polymerize ADP-ribose for DNA repair, while CD38/CD157 hydrolyze NAD+ into cADPR and NAADP, triggering calcium signaling for immunity and circadian rhythms. NAMPT in the salvage pathway sustains NAD+ levels, amplifying these effects—its pathways weave energy, repair, and signaling into a cellular masterpiece (Verdin, 2015; Rajman et al., 2018).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION<a name="ADVERSE_EFFECTS_REPORTED"></a></h4>
<p>NAD+ helps produce energy as NADH in processes like glycolysis and mitochondria. It supports sirtuins for aging control, PARPs for DNA repair, and CD38/CD157 for immune and sleep signals—an enzyme called NAMPT keeps its levels steady.</p>
<h1>METABOLIC AND PHYSIOLOGICAL EFFECTS</h1>
<p>NAD+ turbocharges ATP production by 40–50% in mitochondria (Mills et al., 2016), enhances DNA repair via PARP1 (up to 70% strand break resolution—Rajman et al., 2018), tunes gene expression through sirtuins (e.g., 30% FOXO deacetylation—Gomes et al., 2013), and slashes oxidative stress by 20–30% via SIRT3 (Zhang et al., 2016). It modulates inflammation (e.g., 25% NLRP3 reduction—Cantó et al., 2012) and circadian alignment—systemic vitality in every cell!</p>
<h4>LESS TECHNICAL EXPLANATION<a name="SAFETY_AND_SIDE_EFFECTS"></a></h4>
<p>NAD+ increases cell energy by 40–50%, repairs DNA up to 70%, adjusts genes by 30%, reduces stress by 20–30%, lowers inflammation by 25%, and keeps body rhythms steady—it supports overall cell health.</p>
<h1>SAFETY AND SIDE EFFECTS</h1>
<p>NAD+ is benign at endogenous levels; precursor NR at 1000–2000 mg/day in humans triggers mild flushing (5–10%), nausea (3–5%), or rare fatigue (2%) after 8 weeks (Martens et al., 2018). NMN at 250–500 mg/day shows pristine safety—no adverse effects in 10-week trials (Imai et al., 2021). Rat NAD+ infusions (10 mg/kg) report no toxicity (Zhang et al., 2016)—it’s a cellular saint with gentle precursor quirks!</p>
<h4>LESS TECHNICAL EXPLANATION<a name="ADMINISTRATION_METHODS_RECOMMENDED"></a></h4>
<p>NAD+ is safe at natural levels; NR at 1000–2000 mg/day in people might cause slight flushing, nausea, or tiredness after 8 weeks, while NMN at 250–500 mg/day shows no problems—rat tests at 10 mg/kg are also safe.</p>
<h1>ADMINISTRATION METHODS RECOMMENDED</h1>
<p>In animals, NAD+ is infused intravenously or intraperitoneally at 1 mg/mL in sterile PBS (e.g., 10 mg/kg—Zhang et al., 2016), ensuring rapid tissue delivery. Human precursor NR is dosed orally at 1000–2000 mg/day (Martens et al., 2018), often in capsules; NMN follows suit at 250–500 mg/day (Imai et al., 2021). Reconstituted NAD+ must stay at 2–8°C, used within 24 hours—pH 7.0–7.4, no freeze-thaw chaos!</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>In animals, NAD+ is given through veins or belly at 10 mg/kg in saline; people take NR at 1000–2000 mg/day or NMN at 250–500 mg/day as pills—mixed NAD+ stays refrigerated and is used within a day.</p>
<h1>ADVERSE EFFECTS REPORTED</h1>
<p>NR at 2000 mg/day in humans may spark mild flushing (5–10%), nausea (3–5%), or fatigue (2%) after 8 weeks (Martens et al., 2018); NMN at 500 mg/day is clean (Imai et al., 2021). Rat NAD+ infusions (10 mg/kg) show no harm (Zhang et al., 2016)—minor bumps, no crashes!</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION<a name="KEY_OBSERVATIONS_FROM_PEER_REVIEWED_STUDIES"></a></h4>
<p>NR at 2000 mg/day in people might cause slight flushing, nausea, or tiredness after 8 weeks; NMN at 500 mg/day shows no issues; NAD+ in rats at 10 mg/kg is safe—only mild effects noted.</p>
<h1>KEY OBSERVATIONS FROM PEER REVIEWED STUDIES</h1>
<p>NR hikes NAD+ 60–70% in human blood, boosting HDL 10–15% (Martens et al., 2018); NMN lifts mouse muscle NAD+ 1.7–2.2-fold, endurance 55–65% (Mills et al., 2016); rat NAD+ cuts heart damage 20%, lifts function 30–35% (Zhang et al., 2016)—peer-reviewed gold!</p>
<h4>LESS TECHNICAL EXPLANATION<a name="LIMITATIONS_OF_CURRENT_RESEARCH_DATA"></a></h4>
<p>NR increases blood NAD+ by 60–70% and good cholesterol by 10–15% in people; NMN boosts mouse muscle NAD+ by 1.7–2.2 times and stamina by 55–65%; NAD+ in rats reduces heart damage by 20% and improves function by 30–35%—solid study results.</p>
<h1>LIMITATIONS OF CURRENT RESEARCH DATA</h1>
<p>Precursor human data is solid, but pure NAD+ lacks direct trials due to instability; long-term effects, tissue-specific impacts, and NR vs. NMN superiority are murky (Verdin, 2015). Preclinical models dominate—human scale-up needs bigger cohorts and time.</p>
<h4>LESS TECHNICAL EXPLANATION<a name="OBSERVATIONS_FROM_RESEARCH"></a></h4>
<p>NR and NMN work well in people, but pure NAD+ hasn’t been tested directly because it’s unstable—long-term effects, specific tissue roles, and which helper is better aren’t clear yet; mostly animal data so far.</p>
<h1>RESEARCH BASED OBSERVATIONS</h1>
<p>NAD+ enhances mitochondrial function, DNA repair, and longevity via sirtuins/PARPs; it optimizes metabolic health (insulin sensitivity, lipid profiles) and may protect neurons or vasculature—hypothesized systemic effects on inflammation and circadian rhythms tantalize (Verdin, 2015; Rajman et al., 2018).</p>
<h4>LESS TECHNICAL EXPLANATION<a name="KEY_OBSERVATIONS_FROM_PEER_REVIEWED_STUDIES"></a></h4>
<p>NAD+ improves cell energy, DNA repair, and lifespan; it supports better sugar and fat use, and might protect brain and blood vessels—possibly affecting inflammation and body rhythms too.</p>
<h1>SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO</h1>
<p>In vitro, NAD+ via SIRT1 doubles fibroblast lifespan (Gomes et al., 2013); NMN hikes neuronal NAD+ 30%, cutting oxidative damage 25% (Zhang et al., 2016). In vivo, NR boosts mouse liver NAD+ 2.5–3-fold, glucose uptake 15–20% (Cantó et al., 2012); NMN lifts muscle stamina 55–65% (Mills et al., 2016)—lab-validated dynamite!</p>
<h4>LESS TECHNICAL EXPLANATION<a name="TYPICAL_DOSES_USED_IN_RESEARCH"></a></h4>
<p>In lab cells, NAD+ doubles lifespan with SIRT1 and NMN raises brain NAD+ by 30%, reducing damage by 25%; in mice, NR increases liver NAD+ by 2.5–3 times for 15–20% better sugar use, and NMN boosts muscle stamina by 55–65%.</p>
<h1>TYPICAL DOSES USED IN RESEARCH</h1>
<p>NR at 1000–2000 mg/day in humans (Martens et al., 2018); NMN at 500 mg/kg/day in mice (Mills et al., 2016); NAD+ at 10 mg/kg in rats (Zhang et al., 2016)—species-specific dosing nails efficacy!</p>
<h4>LESS TECHNICAL EXPLANATION<a name="UNANSWERED_QUESTIONS_NEEDING_INVESTIGATION"></a></h4>
<p>People use 1000–2000 mg/day of NR; mice get 500 mg/kg/day of NMN; rats receive 10 mg/kg of NAD+—doses vary by species for good results.</p>
<h1>UNANSWERED QUESTIONS NEEDING INVESTIGATION</h1>
<p>Long-term human safety, tissue-specific NAD+ pool dynamics, precursor efficacy (NR vs. NMN), and direct NAD+ delivery hurdles loom (Verdin, 2015; Rajman et al., 2018)—clinical gaps galore!</p>
<h4>LESS TECHNICAL EXPLANATION<a name="BIOLOGICAL_PROCESSES_OR_CONDITIONS_INFLUENCED"></a></h4>
<p>Questions remain about NAD+’s long-term safety in people, how it works in different tissues, which helper (NR or NMN) is best, and how to deliver it directly—still much to learn.</p>
<h1>BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE</h1>
<p>NAD+ powers a biochemical orchestra, driving redox reactions as NADH in glycolysis (via GAPDH), TCA cycle (via IDH, MDH), and oxidative phosphorylation (ETC complexes I/III), fueling ATP synthesis. It’s a substrate for sirtuins (SIRT1, SIRT3, SIRT6), deacetylating p53, FOXO, and histones for longevity while upregulating PGC-1α for mitochondrial biogenesis. PARPs (PARP1/2) polymerize ADP-ribose for DNA repair, while CD38/CD157 hydrolyze NAD+ into cADPR and NAADP, triggering calcium signaling for immunity and circadian rhythms. NAMPT in the salvage pathway sustains NAD+ levels, amplifying these effects—its pathways weave energy, repair, and signaling into a cellular masterpiece (Verdin, 2015; Rajman et al., 2018).</p>
<h4>LESS TECHNICAL EXPLANATION<a name="POTENTIAL_RESEARCH_EXPLORATIONS"></a></h4>
<p>NAD+ helps produce energy as NADH in processes like glycolysis and mitochondria. It supports sirtuins for aging control, PARPs for DNA repair, and CD38/CD157 for immune and sleep signals—an enzyme called NAMPT keeps its levels steady.</p>
<h1>POTENTIAL RESEARCH EXPLORATIONS</h1>
<p>Explore NAD+ synergy with rapamycin (mTOR), metformin (AMPK), or resveratrol (SIRT1) for amplified anti-aging; target brain or muscle NAD+ pools with novel carriers; test immune or circadian roles—therapeutic horizons beckon (Verdin, 2015; Cantó et al., 2012)!</p>
<p>&nbsp;</p>


</div>

<footer class="blog-post-footer">

  <div class="blog-post-published">
    Feb 23rd 2025
  </div>


  <div class="blog-share">
    <div class="sharing-buttons">

      <a class="sharing-button" href="https://peptidestandard.com/store/nad/#" data-share-button="" data-popup-title="Facebook" data-popup-width="500" data-popup-height="200">
        <i class="icon-facebook"></i>
      </a>








      <a class="sharing-button" href="mailto:?subject=NAD+&amp;body=https://peptidestandard.com/store/nad/">
        <i class="icon-mail"></i>
      </a>








      <a class="sharing-button" href="javascript:;" onclick="window.print()">
        <i class="icon-print"></i>
      </a>

      <a class="sharing-button" href="https://peptidestandard.com/store/nad/#" data-share-button="" data-popup-title="Twitter">
        <i class="icon-twitter"></i>
      </a>












        <a class="sharing-button" href="https://peptidestandard.com/store/nad/#" data-share-button="" data-popup-title="Pinterest" data-popup-width="750" data-popup-height="800">
          <i class="icon-pinterest"></i>
        </a>

</div>

  </div>

</footer>
    </div>

  </section>


</article>






    
  </main><script type="application/ld+json">{"@context":"http://schema.org","@type":"BlogPosting","mainEntityOfPage":{"@type":"WebPage","@id":"https://peptidestandard.com/store/nad/"},"headline":"NAD+","image":{"@type":"ImageObject","url":"[object Object]","height":800,"width":800},"datePublished":"Feb 23rd 2025","dateModified":"Feb 23rd 2025","author":{"@type":"Person","name":""},"publisher":{"@type":"Organization","name":"Peptide Standard","logo":{"@type":"ImageObject","url":"https://cdn11.bigcommerce.com/s-q1sponaupn/images/stencil/original/white_logo_1_1744842452__94063.original.png","width":600,"height":60}},"description":"NAD+"}</script>

  
<section class="navigation-wrap" data-slideout-wrapper="">
  <ul class="navigation-tier navigation-tier-secondary" id="header-pane-category">
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/adipotide/">Adipotide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/aod9604/">AOD9604</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/bpc-157/-1/">BPC 157</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/cagrilintide/-1/">Cagrilintide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/cjc-1295/">CJC-1295</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/dsip/">DSIP</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/epithalon/-1/">Epithalon</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ghk-cu/-1/">GHK-Cu</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ghrp-2/-1/">GHRP-2</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hcg/-1/">HCG</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hexarelin/-1/">Hexarelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hgh/-1/">HGH</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/igf-lr3/">IGF LR3</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ipamorelin/">Ipamorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/kisspeptin/-1/">Kisspeptin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/mots-c/-1/">MOTS-C</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/mt2/">MT2</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/nad/-1/">NAD+</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/oxytocin-acetate/">Oxytocin Acetate</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/peg-mgf/-1/">PEG-MGF</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/pt-141/-1/">PT-141</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/retatrutide/">Retatrutide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/selank/-1/">Selank</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/semaglutide/-1/">Semaglutide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/semax/-1/">Semax</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/sermorelin/-1/">Sermorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/snap-8/-1/">Snap-8</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ss31/">SS31</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/tesamorelin/-1/">Tesamorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymosin-alpha-1/">Thymosin alpha 1</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymosin-4-tb-500/-1/">Thymosin β4 (TB-500)</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymuliin/">Thymuliin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/tirzepatide/-1/">Tirzepatide</a>
      </li>
  </ul>


    <ul class="navigation-tier navigation-tier-secondary" id="header-pane-pages">
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/ali/">Ali</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/cc-auth/">CC AUTH</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/ccform/">CCFORM</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/pnc-27-cancer-research-2025/">PNC-27 CANCER RESEARCH 2025</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/2025researchupdate/">researchupdate</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/periodic-table-final/">Periodic Table Final</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/tool/">Research &amp; Journal Tool</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/blog/">blog</a>
        </li>
        <li class="header-navigation-item has-dropdown">
          <a href="https://peptidestandard.com/contact-us/">Contact Us</a>
            <ul class="navigation-tier navigation-tier-tertiary">
                <li class="header-navigation-item">
                  <a href="https://peptidestandard.com/shipping-returns/">Shipping &amp; Returns</a>

                </li>
            </ul>
        </li>
    </ul>

  <div class="navigation-tier navigation-tier-secondary" id="header-cart-pane">
    <div class="form-field">
      <label class="quick-cart-currency form-label" for="quick_cart_currency_change">
      <span class="quick-cart-change-currency form-label-text">
        Currency:
          US Dollars
      </span>
      </label>
    </div>

    <div id="quick-cart" class="quick-cart empty" data-count="0">
  <div data-quick-cart-content="">
    <div class="quick-cart-content-area">


    <div class="empty-cart">Your cart is empty.</div>

</div>
  </div>

  <div data-quick-cart-totals="">
    
  </div>
</div>
  </div>
</section>
  <footer class="main-footer">

  <div class="container footer-interactions">
    <div class="layout-module">
      <div class="footer-navigation footer-navigation-list-item">
        <nav class="main-footer-menu">
  <ul class="nav-menu navigation-tier">
    <li>
      <a href="https://peptidestandard.com/store/nad/#header-pane-category" data-slideout-menu="">Products</a>
    </li>
    <li>
      <a href="https://peptidestandard.com/store/nad/#header-pane-pages" data-slideout-menu="">Information</a>
    </li>
    <li><a href="https://peptidestandard.com/store/nad/#modal-search" class="toggle-search">Search</a></li>
    <li><a href="https://peptidestandard.com/store/nad/#header-cart-pane" data-slideout-menu="">Cart</a></li>
  </ul>
</nav>

      </div>

    </div>
  </div>
  <div class="layout-module">
    <div class="footer-content">
        <div class="footer-content-column mailing-list-wrapper">
          <section class="mailing-list footer-module">
  <h3 class="section-title">Join our mailing list</h3>

  <p>We promise to send only good things.</p>

  <form class="mailing-list-form" action="https://peptidestandard.com/subscribe.php" method="post" data-validates="" novalidate="true">
    <input type="hidden" name="action" value="subscribe">
    <input type="hidden" name="check" value="1">
    <input type="hidden" name="nl_first_name" value="bc">

    <div class="form-field full-width-field">
      <label class="form-label" for="nl_email">
        <span class="form-label-text">Email Address</span>
        <input class="form-input mailing-list-email" id="nl_email" name="nl_email" type="email" value="michael@dreamkidstudio.com">
      </label>

      <input class="mailing-list-submit form-input" type="submit" name="subscribe" value="">
    </div>
  </form>

</section>
        </div>

      <div class="footer-content-column">
          <address class="footer-contact-address">
            5820 w Greenway rd Suite 124<br>
Glendale, AZ 85306
          </address>

      </div>
    </div>

    <div class="footer-quick-links">

        <ul class="footer-account-links">
            <li>
              <a href="https://peptidestandard.com/account.php">
                Your Account
              </a>
            </li>
            <li>
              <a href="https://peptidestandard.com/login.php?action=logout">
                Logout
              </a>
            </li>
        </ul>


      <ul class="footer-page-links">
        <li>
          <a href="https://peptidestandard.com/sitemap.php">
            Sitemap
          </a>
        </li>
      </ul>

      <ul class="footer-payment-icons">
          <li>
            <span class="payment-icon">
              <i class="icon-payment-visa"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-mastercard"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-american-express"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-discover"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-paypal"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-apple-pay"></i>
            </span>
          </li>
      </ul>

      <div data-content-region="ssl_site_seal--global"></div>
    </div>
  </div>

  <div class="layout-module">
    <p class="copyright" role="contentinfo">© <script nonce="">document.write(new Date().getFullYear())</script>2025 <a href="https://peptidestandard.com/">Peptide Standard</a></p>
      <p class="footer-attribution">
        Powered by <a href="https://www.bigcommerce.com/" target="_blank" rel="nofollow">BigCommerce</a>
      </p>
  </div>
</footer>
  <div class="navigation-overlay"></div>
<div class="error-message-modal"></div>

<div class="search-overlay">

  <!-- snippet location forms_search -->

  <form class="search-overlay-form" id="modal-search" action="https://peptidestandard.com/search.php">
    <div class="form-field-inline">
      <input class="search-overlay-input" name="search_query" placeholder="Search the store">
      <a class="button button-invisible-thin search-overlay-close" href="https://peptidestandard.com/store/nad/#modal-search">
        <i class="icon-close"><span class="sr-only">Close</span></i>
      </a>
    </div>
    <input class="button button-invisible search-overlay-submit" type="submit" value="Search">
  </form>

</div>


<div class="loading-overlay">
  <span class="page-spinner"></span>
</div>

  
<script type="application/ld+json">{"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://peptidestandard.com/","name":"Home"}},{"@type":"ListItem","position":2,"item":{"@id":"https://peptidestandard.com/blog/","name":"blog"}},{"@type":"ListItem","position":3,"item":{"@id":"https://peptidestandard.com/store/nad/","name":"NAD+"}}]}</script>

  <script nonce="">window.__webpack_public_path__ = "https://cdn11.bigcommerce.com/s-q1sponaupn/stencil/5bfdbf40-0203-013e-7707-7ab084116f26/e/a8ba4540-0218-013e-bf9c-661f783446da/dist/";</script>
  <script nonce="" src="./NAD+ - Peptide Standard_files/theme-bundle.main.js"></script>
  <script nonce="">
    window.stencilBootstrap("pages/blog-post", "{\"themeImageSizes\":[],\"breakPoints\":{\"xlarge\":{\"start\":1200,\"end\":1400},\"medium\":{\"start\":569,\"end\":850},\"small\":{\"start\":0,\"end\":568},\"xxlarge\":{\"start\":1401,\"end\":99999},\"large\":{\"start\":851,\"end\":1199}},\"productsPerPage\":9,\"disableProductAjax\":false,\"cartUrl\":\"/cart.php\",\"carouselDelay\":null,\"compareCompareProducts\":\"Compare\",\"compareClearSelection\":\"Clear Selection\",\"homeLink\":\"https://peptidestandard.com/\",\"continueShopping\":\"continue shopping\",\"urlsCart\":\"/cart.php\",\"urlsCheckout\":\"/checkout\",\"messagesCartLink\":\"cart\",\"messagesCartQuantityError\":\"We were unable to add this product to your cart. Please try again later. Contact us if you continue to have issues.\",\"messagesCheckoutLink\":\"check out\",\"messagesProductGeneral\":\"We were unable to add this product to your cart. Please try again later. Contact us if you continue to have issues.\",\"messagesProductAddSuccess\":\"*product* has been successfully added to your *cart_link*. Feel free to *continue_link* or *checkout_link*.\",\"messagesProductAddSuccessAlert\":\"*product* has been successfully added to your cart.\",\"productOutOfStock\":\"Unfortunately, we do not have *quantity* in stock.\",\"productAddToCart\":\"Add to Cart\",\"productPreOrder\":\"Pre-Order\",\"productSoldOut\":\"Sold Out\",\"productYouSave\":\"You save\",\"productIncludingTax\":\"(Inc. Tax)\",\"productExcludingTax\":\"(Exc. Tax)\",\"productPreviewVariation\":\"Preview Variation\",\"productOptionUnavailable\":\"This option is currently unavailable.\",\"salePriceLabel\":\"Now:\",\"nonSalePriceLabel\":\"Was:\",\"retailPriceLabel\":\"MSRP:\",\"priceLabel\":\"\",\"messagesWishlistAddSuccess\":\"*product* successfully added to *name*.\",\"messagesWishlistAddError\":\"*product* could not be added to wishlist.\",\"validationRequired\":\"This field is required.\",\"validationEmail\":\"Your E-mail address appears to be invalid.\",\"validationNumber\":\"You can enter only numbers in this field.\",\"validationNumMax\":\"Please enter a number less than undefined.\",\"validationNumMin\":\"Please enter a number greater than undefined.\",\"validationNumRange\":\"Please enter a number greater than undefined and less than undefined.\",\"validationMaxLength\":\"Maximum undefined characters allowed.\",\"validationMinLength\":\"Minimum undefined characters allowed.\",\"validationMaxChecked\":\"Maximum undefined options allowed.\",\"validationMinChecked\":\"Please select minimum undefined options.\",\"validationMaxSelected\":\"Maximum undefined selection allowed.\",\"validationMinSelected\":\"Minimum undefined selection allowed.\",\"validationNotEqual\":\"Fields do not match.\",\"validationDifferent\":\"Fields cannot be the same as each other.\",\"showMore\":\"Show More\",\"hideMore\":\"Hide Extras\",\"zoomClose\":\"Close (Esc)\",\"zoomShare\":\"Share\",\"zoomFullscreen\":\"Toggle fullscreen\",\"zoomAction\":\"Zoom in/out\",\"zoomPrevious\":\"Previous (arrow left)\",\"zoomNext\":\"Next (arrow right)\",\"customerID\":3}").load();
  </script>
  <script type="text/javascript" src="./NAD+ - Peptide Standard_files/csrf-protection-header-5eeddd5de78d98d146ef4fd71b2aedce4161903e.js"></script>
<script src="./NAD+ - Peptide Standard_files/collector.js" async=""></script><script src="./NAD+ - Peptide Standard_files/q1sponaupn.js" defer=""></script><script>// Enhance product page for scientific products
document.addEventListener('DOMContentLoaded', function() {
  // Only run on product pages
  if (!document.querySelector('.productView')) return;
  
  // Find the iframe and enhance it
  const iframes = document.querySelectorAll('.productView-description iframe');
  iframes.forEach(iframe => {
    const wrapper = document.createElement('div');
    wrapper.className = 'molecule-display';
    iframe.parentNode.insertBefore(wrapper, iframe);
    wrapper.appendChild(iframe);
  });
  
  // Enhance chemical formulas
  const formulas = document.querySelectorAll('.productView-info-value');
  formulas.forEach(formula => {
    if (formula.textContent.includes('Molecular Formula')) {
      formula.classList.add('chemical-formula');
    }
  });
});</script><script><style>
/* High-specificity selectors to ensure our styles take effect */
html body.page-type-product .productView-title,
html body.page-type-product h1.productView-title {
  font-weight: 800 !important;
  text-transform: uppercase !important;
  border-bottom: 2px solid #3fe2ae !important;
  display: inline-block !important;
  padding-bottom: 5px !important;
  color: #ffffff !important;
}

html body.page-type-product .productView,
html body.page-type-product div.productView {
  background-color: rgba(18, 18, 18, 0.8) !important;
  color: #ffffff !important;
  padding: 20px !important;
  border-radius: 10px !important;
  margin-top: 20px !important;
}

html body.page-type-product .productView-details,
html body.page-type-product div.productView-details {
  background: rgba(30, 30, 30, 0.8) !important;
  border-radius: 10px !important;
  padding: 20px !important;
  margin-bottom: 20px !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.2) !important;
}

html body.page-type-product .productView-info-name,
html body.page-type-product span.productView-info-name {
  color: rgba(255, 255, 255, 0.7) !important;
  font-weight: 600 !important;
}

html body.page-type-product .productView-info-value,
html body.page-type-product span.productView-info-value {
  color: #ffffff !important;
  font-weight: 500 !important;
}

html body.page-type-product .productView-price .price,
html body.page-type-product span.price {
  color: #3fe2ae !important;
  font-weight: 700 !important;
}

html body.page-type-product .button--primary,
html body.page-type-product button.button--primary {
  background: linear-gradient(45deg, #ff6448 0%, #3fe2ae 100%) !important;
  border: none !important;
  border-radius: 5px !important;
  color: white !important;
  font-weight: 600 !important;
  transition: all 0.3s ease !important;
}

html body.page-type-product .productView-description,
html body.page-type-product div.productView-description {
  background: rgba(30, 30, 30, 0.8) !important;
  border-radius: 10px !important;
  padding: 30px !important;
  margin-top: 30px !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.2) !important;
  color: #ffffff !important;
}

html body.page-type-product .productView-description iframe,
html body.page-type-product div.productView-description iframe {
  border-radius: 8px !important;
  margin: 20px auto !important;
  display: block !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.3) !important;
}

html body.page-type-product .form-input, 
html body.page-type-product .form-select,
html body.page-type-product input.form-input,
html body.page-type-product select.form-select {
  background-color: rgba(255, 255, 255, 0.1) !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  border-radius: 5px !important;
  color: white !important;
}

/* Target the entire page background */
html body.page-type-product,
html body.page-type-product div.body,
html body.page-type-product div.page,
html body.page-type-product div.page-content {
  background-color: #121212 !important;
  color: #ffffff !important;
}
</style>


// Enhance molecular visualization
document.addEventListener('DOMContentLoaded', function() {
  // Find any iframe (likely molecular visualization)
  const iframes = document.querySelectorAll('.productView-description iframe');
  
  if (iframes.length > 0) {
    iframes.forEach(iframe => {
      // Create wrapper for the iframe
      const wrapper = document.createElement('div');
      wrapper.className = 'molecule-wrapper';
      wrapper.style.cssText = `
        width: 100%;
        max-width: 500px;
        margin: 30px auto;
        border-radius: 10px;
        overflow: hidden;
        background: linear-gradient(145deg, #193338, #3fe2ae);
        padding: 10px;
      `;
      
      // Add a title for the visualization
      const title = document.createElement('h3');
      title.textContent = 'Molecular Structure';
      title.style.cssText = `
        text-align: center;
        color: white;
        margin-bottom: 10px;
        font-weight: 700;
      `;
      
      // Apply enhancements
      iframe.parentNode.insertBefore(wrapper, iframe);
      wrapper.appendChild(title);
      wrapper.appendChild(iframe);
      
      iframe.style.width = '100%';
      iframe.style.height = '300px';
      iframe.style.border = 'none';
      iframe.style.borderRadius = '8px';
      iframe.style.backgroundColor = 'white';
    });
  }
});
</script><script>// Square configuration
const SQUARE_CONFIG = {
    accessToken: 'EAAAlylhEhDMU-sjv66Su8B2oQMgVxQja85xuoJLcURWEimX4xYdUXnGHF6LfTBW',
    locationId: 'x89XVH1D1Y6PKM',
    environment: 'production'
};

// Square Invoice Handler
async function createSquareInvoice(formData) {
    try {
        const response = await fetch('https://connect.squareup.com/v2/invoices', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                invoice: {
                    location_id: SQUARE_CONFIG.locationId,
                    primary_recipient: {
                        customer_id: await findOrCreateCustomer(formData.customerInfo)
                    },
                    payment_requests: [{
                        request_method: 'EMAIL',
                        request_type: 'BALANCE',
                        due_date: new Date(Date.now() + 30 * 24 * 60 * 60 * 1000).toISOString().split('T')[0]
                    }],
                    delivery_method: 'EMAIL',
                    line_items: formData.lineItems.map(item => ({
                        quantity: item.quantity.toString(),
                        name: item.product,
                        base_price_money: {
                            amount: Math.round(parseFloat(item.price) * 100),
                            currency: 'USD'
                        }
                    }))
                }
            })
        });

        if (!response.ok) {
            throw new Error('Failed to create invoice');
        }

        const result = await response.json();
        alert('Invoice created successfully!');
        return result;
    } catch (error) {
        console.error('Error creating Square invoice:', error);
        alert('Failed to create invoice. Please try again.');
        throw error;
    }
}

// Find or create customer in Square
async function findOrCreateCustomer(customerInfo) {
    try {
        // Search for existing customer
        const searchResponse = await fetch('https://connect.squareup.com/v2/customers/search', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                query: {
                    filter: {
                        email_address: {
                            exact: customerInfo.email
                        }
                    }
                }
            })
        });

        const searchResult = await searchResponse.json();
        
        if (searchResult.customers?.length > 0) {
            return searchResult.customers[0].id;
        }

        // Create new customer if not found
        const createResponse = await fetch('https://connect.squareup.com/v2/customers', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                idempotency_key: Date.now().toString(),
                given_name: customerInfo.name,
                email_address: customerInfo.email,
                phone_number: customerInfo.phone,
                address: {
                    address_line_1: customerInfo.address,
                    locality: customerInfo.city,
                    administrative_district_level_1: customerInfo.state,
                    postal_code: customerInfo.zip,
                    country: 'US'
                }
            })
        });

        const createResult = await createResponse.json();
        return createResult.customer.id;
    } catch (error) {
        console.error('Error finding/creating customer:', error);
        throw error;
    }
}

// Initialize when DOM is loaded
document.addEventListener('DOMContentLoaded', function() {
    // Add event listener to the Square Invoice button
    const squareInvoiceBtn = document.getElementById('createSquareInvoiceBtn');
    if (squareInvoiceBtn) {
        squareInvoiceBtn.addEventListener('click', async function() {
            const formData = collectFormData();
            await createSquareInvoice(formData);
        });
    }
});</script>      <script>
        (function() {
          window.shogunVariables = {};
          window.shogunVariables.orderId = '';
        })();
      </script>
<script>
(function(){if(!window.chatbase||window.chatbase("getState")!=="initialized"){window.chatbase=(...arguments)=>{if(!window.chatbase.q){window.chatbase.q=[]}window.chatbase.q.push(arguments)};window.chatbase=new Proxy(window.chatbase,{get(target,prop){if(prop==="q"){return target.q}return(...args)=>target(prop,...args)}})}const onLoad=function(){const script=document.createElement("script");script.src="https://www.chatbase.co/embed.min.js";script.id="rcNL6wxGDLSXXSo1wljpQ";script.domain="www.chatbase.co";document.body.appendChild(script)};if(document.readyState==="complete"){onLoad()}else{window.addEventListener("load",onLoad)}})();
</script>

  <!-- snippet location footer -->
  

<script src="./NAD+ - Peptide Standard_files/embed.min.js" id="rcNL6wxGDLSXXSo1wljpQ"></script><style>
#chatbase-bubble-button,
#chatbase-bubble-button * {
margin: 0;
padding: 0;
box-sizing: border-box;
}
html.__cb_widget_active,
html.__cb_widget_active body {
position: fixed !important;
top: 0;
left: 0;
overscroll-behavior: none;
width: 0 !important;
height: 0 !important;
margin: 0 !important;
overflow: hidden !important;
overflow-y: hidden !important;
overflow-x: hidden !important;
transform: none !important;
}

#chatbase-bubble-window {
border: 1px solid #F4F4F5;
box-shadow: 0px 260px 73px 0px rgba(0, 0, 0, 0.00), 0px 166px 67px 0px rgba(0, 0, 0, 0.01), 0px 94px 56px 0px rgba(0, 0, 0, 0.02), 0px 42px 42px 0px rgba(0, 0, 0, 0.03), 0px 10px 23px 0px rgba(0, 0, 0, 0.04);
backdrop-filter: blur(4px);
-webkit-backdrop-filter: blur(4px);
}

</style><div id="chatbase-message-bubbles" style="position: fixed; bottom: 85px; border-radius: 10px; font-family: sans-serif; font-size: 16px; z-index: 2147483644; cursor: pointer; flex-direction: column; gap: 50px; max-width: 70vw; display: none; right: 1rem; left: unset;"><div style="position: absolute; top: -7px; right: -7px; font-weight: bold; display: none; justify-content: center; align-items: center; z-index: 2147483643; width: 22px; height: 22px; border-radius: 50%; text-align: center; font-size: 12px; cursor: pointer; background-color: rgb(51, 51, 51); color: white; box-shadow: rgba(150, 150, 150, 0.15) 0px 6px 24px 0px, rgba(150, 150, 150, 0.15) 0px 0px 0px 1px;">✕</div><div style="display: flex; justify-content: flex-end;"><div style="background-color: black; color: white; box-shadow: rgba(150, 150, 150, 0.2) 0px 10px 30px 0px, rgba(150, 150, 150, 0.2) 0px 0px 0px 1px; border-radius: 10px; padding: 20px; margin: 8px; font-size: 14px; opacity: 0; transform: scale(0.9); transition: opacity 0.5s, transform 0.5s;">Hey there! You need assistance with anything?</div></div></div><button type="button" id="chatbase-bubble-button" aria-label="chat-button" style="position: fixed; border: 0px; bottom: 1rem; right: 1rem; width: 55px; height: 55px; border-radius: 27.5px; background-color: rgb(243, 255, 168); box-shadow: rgba(0, 0, 0, 0.2) 0px 4px 8px 0px; cursor: pointer; z-index: 2147483645; transition: 0.2s ease-in-out; left: unset;"><div style="display: flex; align-items: center; justify-content: center; width: 100%; height: 100%; z-index: 2147483646;"><img src="./NAD+ - Peptide Standard_files/bV4iIfaGa67MbMybykThp.jpg" alt="Total Health Pro" style="width: 55px; height: 55px; border-radius: 50%;"></div></button><div id="chatbase-bubble-window" style="border: none; position: fixed; flex-direction: column; justify-content: space-between; bottom: 85px; right: 1rem; width: 406px; height: 85dvh; max-height: 824px; border-radius: 1.25rem; display: none; z-index: 2147483646; overflow: hidden; background-color: black; left: unset;"><div style="display: flex; justify-content: center; height: 100%; align-items: center;"><svg viewBox="0 0 30 30" xmlns="http://www.w3.org/2000/svg" stroke="white" style="width:30px;height:30px;">
  <g>
      <rect x="11" y="1" width="2" height="5" opacity=".14"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(30 12 12)" opacity=".29"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(60 12 12)" opacity=".43"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(90 12 12)" opacity=".57"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(120 12 12)" opacity=".71"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(150 12 12)" opacity=".86"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(180 12 12)"></rect>
      <animatetransform attributeName="transform" type="rotate" calcMode="discrete" dur="0.75s" values="0 12 12;30 12 12;60 12 12;90 12 12;120 12 12;150 12 12;180 12 12;210 12 12;240 12 12;270 12 12;300 12 12;330 12 12;360 12 12" repeatCount="indefinite"></animatetransform>
  </g>
</svg></div><iframe title="Total Health Pro" style="height: 100%; width: 100%; border: none; display: none;" src="./NAD+ - Peptide Standard_files/saved_resource(2).html"></iframe></div></body></html>